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This work investigated the use of a common medical device, a thyroid uptake system or 
thyroid probe, in assessing internal contamination in individuals.  In the event of a terrorist act 
involving a radiological agent, there will be a need to effectively and rapidly screen a large 
number of people for internal contamination.  Using the methodology outlined in this work, 
those needing further medical assistance can be identified and separated from uncontaminated or 
very lightly contaminated people.  Additionally, this information could be stored in a registry to 
track population contamination. 
A series of measurements and models were used to estimate the response of the thyroid 
probe to radioactive isotopes in various human phantoms.  First, benchmark measurements were 
made using a polymethyl methacrylate (PMMA) slab phantom and a variety of gamma-ray 
emitting isotopes.  The experimental setup was recreated in a computational model using the Los 
Alamos Monte Carlo N-Particle Transport Code, MCNP5. [45] The thyroid uptake collimator 
was also modeled using this code and simulations were completed for each laboratory 
measurement.  A comparison of these results validated the computational model of the thyroid 
uptake collimator and provided any required normalization factors. 
Six anthropomorphic phantoms of varying age and body type were then used in 
conjunction with the thyroid uptake collimator.  These phantoms are based on the Medical 
Internal Radiation Dose (MIRD) phantoms [7], originally developed at Oak Ridge National 
Laboratory.  Uniformly distributed isotopic sources were placed in all the affected organs 
according to biokinetic models generated by the Dose and Risk Calculation Software (DCAL). 
[9] 
xiv 
The results of this work demonstrate that the thyroid uptake probe is a viable tool for 
assessing internal contamination due to Cs-137, Co-60, I-131, and Ir-192, even at relatively high 
levels of background.  However, this work found that a collimated thyroid uptake probe could 
not be used to assess individuals internally contaminated with Am-241.  The Decision Level 
(DL) count rate for Am-241 exceeds the expected count rate due to an intake of one Clinical 
Decision Level (1 CDL is approximately 25 rem) by several orders of magnitude.  The most 
effective location of the thyroid probe for Co-60 and Ir-192 is on the back over the right lung.  
Two of the isotopes investigated, I-131 and Cs-137, have a recommended lung absorption type 
of fast.  This results in a higher uptake to various tissues, and a smaller fraction of the isotope 
remaining in the lungs.  Thus, for these isotopes, positioning the detector against the neck 
produces the highest count rate.  In general, an increase in body mass index (BMI) adversely 








After the events of September 11, 2001, the threat of a terrorist act involving chemical, 
biological, or radiological agents has demanded the attention of government officials and public 
health agencies.  While the ultimate consequence of such an event is difficult to predict, the 
psychological and economic impact on the United States could be devastating. 
With regard to radiological terrorism, weapons are no longer limited to atomic bombs or 
nuclear devices, such as those used at Hiroshima and Nagasaki.  The dispersal of radioactive 
material into the environment – with or without an associated explosion – is now considered a 
principal threat. [6] A Radiological Dispersal Device (RDD) is a particular concern due to the 
widespread use of radioactive materials in foreign and domestic industries. [2] 
Radioactive materials are used in the petroleum industry, in health care for diagnostic and 
therapeutic applications, and in electric power generation.  The applications of these materials 
are as diverse as the isotopes themselves.  A work conducted at Sandia National Laboratories 
examined radioactive materials at facilities licensed by the Nuclear Regulatory Commission 
(NRC) and controlled and managed by the Department of Energy (DOE).  The purpose of the 
analysis was to determine the relative availability of several nuclear materials and to identify 
those of greatest concern, or those thought to be most likely used in a RDD.  The materials 
identified by Sandia National Laboratories include Am-241, Cs-137, Co-60, and Ir-192. [36] 
One principal health threat resulting from a RDD is internal contamination due to 
inhalation.  Radioactive dust or smoke resulting from an associated explosion or particulate 
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radioactive materials dispersed into the air could be inhaled and subsequently spread throughout 
the individual’s body.  Depending on the isotope, a significant fraction of the intake could 
remain in the lungs up to several days. This is the optimal window of time to assay internal 
contamination and make determinations of the need for further medical care to ameliorate the 
health impact.  
Recent publications have examined the feasibility of using a thyroid uptake system to 
monitor personal internal contamination due to inhalation. [24, 1] As a common nuclear 
medicine apparatus, the thyroid uptake system is readily available in hospital Nuclear Medicine 
departments, and is a functional tool for use in an emergency scenario.  The ultimate choice in 
assaying internal contamination, particularly for trace amounts of internal contamination, is a 
whole body counter (WBC) such as those found at nuclear power facilities.   WBCs are highly 
sensitive, and this level of sensitivity is more than what is needed for emergency triage.  In 
addition, these devices are rarely found in major cities, and in the absence of WBCs, other 
common radiation detectors have been considered for the rapid and effective triage of potentially 
contaminated victims.    
This work attempts to determine count rates corresponding to various Clinical Decision 
Levels (CDLs) using Monte Carlo simulation techniques for the Captus 3000 Thyroid Uptake 
System.  For the purpose of this work, one CDL is defined as the intake that results in 25 rem of 
committed effective dose. [34] This unit was recommended by the Centers for Disease Control 
and Prevention to be used to quantify count rate thresholds for emergency procedure protocols.  
Six Medical Internal Radiation Dose (MIRD) phantom types were also examined to estimate the 






In addition to many individuals and organizations, the Centers for Disease Control and 
Prevention (CDC) and the Nuclear Regulatory Commission (NRC) have published several recent 
documents concerning emergency medical response to a RDD.  These documents include 
feasibility reports, guidelines, and evaluations of current levels of preparedness.  One such 
document, published by the Belgian Nuclear Research Center, discussed the direct and indirect 
effects of a radiological attack on a populous area.  The direct and immediate effects could 
include death, injury, contamination, and societal chaos.  Delayed effects regarding 
contamination of food or water supplies and the economic ramifications of such a disaster also 
present a unique problem. [39] The principal concern is a need for preparedness – both in 
emergency response and in addressing the long-term effects of such an event.   
Several studies have addressed the risk and potential dose to healthcare providers treating 
contaminated victims following a radiological terrorist event.  According to surveys conducted 
among medical personnel, there exists a significant concern about the risk associated with 
treating a radioactively-contaminated patient.  Despite these concerns, medical guidelines state 
that the treatment of life-threatening injuries and medical stabilization of a patient should not be 
delayed for decontamination efforts. [38] 
The standard for assessing contamination (both internal and external) in radiation 
occupations is a Whole Body Counter (WBC).  A WBC is generally constructed of an array of 
NaI(Tl) detectors surrounded by some back-ground reducing material.  WBCs can be orientated 
such that the individual walks into or through the detectors.  Numerous studies have been 
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conducted on the efficiency and sensitivity of WBCs for applications both in emergency 
response and occupational monitoring.  One emergency scenario in which a WBC was employed 
was following the Cs-137 accident in Goiania, Brazil.  This system was constructed in the field 
using a 20 cm NaI(Tl) mounted approximately 2 m off the ground in a small room.  This detector 
was used to successfully assay over 300 people following the accident. [33]  
Internal contamination is a primary cause of committed effective dose to the victim 
following an RDD. The development of instruments and protocols to estimate internal 
contamination is the topic of recent studies conducted at the Georgia Institute of Technology.  
These studies have examined a variety of instruments for both their feasibility and efficiency in 
detecting internal contamination due to inhalation of radioactive material. 
A study conducted by S. Cohen and Associates [1] evaluated the feasibility of using 
various hospital radiation detectors to assess internal contamination from inhaled radionuclides.  
The detection systems included in this study are commonly found in hospitals, especially those 
performing nuclear medicine studies.  Based on simulations using an acrylic slab phantom and a 
water filled phantom, the SC&A study concluded that the gamma camera, thyroid uptake system, 
and waste monitor are each capable of detecting low levels of radiation and can potentially be 
used in the aftermath of a terrorist event.  
With regard to the thyroid uptake system, the SC&A investigation looked specifically at 
the Atomlab 950 Thyroid Uptake System.  The Atomlab 950 consists of a 2” by 2” NaI crystal 
with a lead collimator extending approximately six inches from the detector face. This is the 
same thyroid uptake system that was the primary focus of a thesis completed by Ryan Lorio. [24] 
The Lorio work also sought to examine the feasibility of using a thyroid uptake system for 
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estimating dose to individuals following a terrorist event; and furthermore, it sought to develop a 
validated Monte Carlo model of this probe to estimate uptake to the lungs.  
While the work completed by Lorio proved that the use of this system is feasible 
following an RDD, the models considered did not include the movement of an isotope through 
the body, or the fraction remaining in various organs over time.  To further refine the 
conclusions, this work will include biokinetic modeling while determining the detector response 










3.1 Captus 3000 Thyroid Uptake System Overview 
The Captus 3000 Thyroid Uptake System is manufactured by Capintec, Inc, and is a fully 
automated, PC-based system which is typically used to perform thyroid uptake tests, bioassay 
tests, and other lab tests.  The system includes two 2” Sodium-Iodide (NaI) detectors mounted on 
articulating spring arms, a 1024-channel multi-channel analyzer (MCA), and several modules for 
calibration, measurements, and reporting.  Both detectors are collimated with a lead-antimony 
composite material.  The thyroid uptake collimator is longer, extending approximately 16 
centimeters from the detector face.  The bioassay collimator is shorter, extending only 
approximately six centimeters from the detector.  All Captus 3000 thyroid uptake systems 
include the thyroid uptake collimator while the bioassay collimator is an optional feature.  The 
focus of this work is on the standard thyroid uptake collimator.  The system stores patient 
information and demographics as well as all collected spectral or counting data.  These features 
are very useful for generating detailed thyroid uptake reports and staff bioassays; reports can be 
saved and printed as individual reports or as a cumulative history.  The Captus 3000 system is 




Figure 3.1.1 Capintec Captus 3000 Thyroid Uptake System with thyroid uptake collimator. 
 
 
As specified in the user’s manual, the Captus 3000 must be auto-calibrated using two 
calibration sources (Cs-137 and Eu-152, included with system) daily before measurements are 
collected or tests are performed.  In addition, the chi-squared calibration test must be performed 
before initial use, and then quarterly.  All calibration tests were performed successfully at 
Georgia Tech prior to data collection.  
The manual MCA interface was used for all measurements in this work.  The MCA 
calibration is set to 2 keV per channel, allowing it to bin pulse-height data for gamma energies 
up to 2 MeV.  The MCA system is equipped to automatically identify the regions of interest 
(ROI) based on an isotope selection.  It is unrealistic to expect emergency operators to manually 
adjust the ROIs in the field.  Therefore, the system default ROIs set on photopeaks were used in 
both the data collection and the model validation.  Each MCA spectrum report was exported as a 






3.2 Measurements using PMMA Slab Phantom 
 The thyroid uptake collimator was used to make a series of benchmark measurements 
with various isotopes.  The measurements were made using a slab phantom composed of  
polymethyl methacrylate (PMMA) and virtual water.  PMMA was chosen for its attenuation 
properties, which are similar to those of human tissue.  Virtual WaterTM (MED-CAL, Inc., 
Verone, WI) [43] was used as backscatter material, placed furthest from the detector face and 
behind the source.  The thickness of the backscatter material was 10-cm for all measurements.  A 
6-mm thick PMMA ‘source holder’ was placed flush against the virtual water.  A cylindrical 
hole in the center of the source holder contained the source, preventing the source from shifting 
during measurements.  Slabs of PMMA were placed in front of the source holder to increase or 
decrease the thickness of attenuating material between the source and the detector.  The 












The source was centered on the opening of the collimator, and taped in place to prevent 
movement during a set of measurements.  The source position relative to the detector face is 
shown in Figure 3.2.2.  The position of the source holder relative to the PMMA, Virtual Water, 
and detector is shown above in Figure 3.2.1. 
 
 
Figure 3.2.2 Position of source relative to detector. 
 
Some of the isotopes of greatest concern for use in a RDD are Co-60, Cs-137, and Am-
241.  These isotopes, along with three others, were used to encompass a broad range of gamma-
ray energies.  This selection was based largely on the availability of the sources.  The isotopes 
that were used in detector characterization and their associated photon energies and intensities 

















Table 3.2.1 Selected isotopes and photon energies for benchmark measurements and detector validation 
Isotope Photon Energy, MeV Photon Emission Intensity 
Am-241 
0.059, 0.026, 0.021, 0.0179, 0.0177, 
0.017, 0.0168, 0.0139, 0.0137 
0.357, 0.024, 0.045, 0.019, 0.188, 0.022, 
0.058, 0.219, 0.024 
Ba-133 
0.384, 0.356, 0.303, 0.276, 0.081, 0.035, 
0.031, 0.030 
0.089, 0.622, 0.184, 0.071, 0.338, 0.122, 
0.631, 0.341 
Cs-137 0.662 0.853 
Co-60 1.332, 1.173 0.999, 0.999 
Mn-54 0.8348 0.999 
Na-22 1.275, 0.511 0.999, 1.798 
 
 For each measured isotope, a spectrum was collected for PMMA thicknesses ranging 
from 0-mm to 108-mm in six millimeter increments.  Counting time was determined based on 
counting in the ROI.  A minimum of 10,000 counts before background subtraction 
(corresponding to 1% counting error under the peak) was specified for each thickness.   
 Background corrections were applied to the spectra outside of the Capintec software.  
Before each set of measurements, a ten minute background spectrum was acquired and then 
subtracted from each of the measured spectra.  No other corrections were made to the raw data. 
 
3.3 Detector Model and Validation 
 The benchmark measurements were used to validate a computational model of the 
thyroid uptake collimator and detector.  The purpose of this model was to accurately represent 
the detector so that simulations on contaminated ‘people’ could be performed using computer 




The detector response was calculated for the same PMMA thicknesses as the benchmark 
measurements.  Also, the response to each isotope was calculated separately to ensure that the 
detector model was validated over a range of gamma-ray energies.  
The measured pulse-height spectra were individually integrated over the entire spectrum, 
and over each photopeak.  These values were compared to the corresponding calculated detector 
response for each isotope and each thickness of PMMA.  Validation of the model requires that 
the ratio of calculated to measured count rate is constant over the range of attenuation 
thicknesses.   
 
3.4 Development of Emergency Screening Protocols 
 The validated detector model was used to simulate the detector response on an internally 
contaminated human.  Medical Internal Radiation Dose (MIRD) male and female phantoms 
based on the reference man were used.  These phantoms were originally developed at Oak Ridge 
National Laboratory. [7] The MCNP models of the reference male and female phantoms were 
developed at the Pacific Northwest National Laboratory in the late 1980’s.  These phantoms have 
been used and further refined at the Georgia Institute of Technology in dose conversion 
coefficient studies in recent years.  One of the major works at Georgia Tech on these phantoms 
was the addition of adipose tissue to the reference male and female phantoms to create three 
additional phantoms: Adipose Male, Adipose Female, and Post-Menopausal Adipose Female. 
[37] Other modifications made to the phantoms include the addition of an esophagus and a 
walled colon.  A child phantom was created using the Bodybuilder Phantom [44] and included in 
the simulations.  In total, six anthropomorphic phantoms were used: Male, Female, Adipose 
Male, Adipose Female, Post-Menopausal Adipose Female, and a 10-year-old Child.   
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Five sources were chosen based on those noted by the Nuclear Regulatory Commission 
as being “isotopes of greatest concern.’ [6]  These sources (Cs-137, Co-60, Am-241, I-131, and 
Ir-192) have distributions in various organs in the human body as a function of time when 
inhaled.  To fully characterize the isotopes behavior in the body, the isotopes were distributed 
throughout the organs based on biokinetic models for inhalation.  Details concerning biokinetic 
modeling are further described in Chapter 5.  Table 3.4.1 shows the energy and intensity for the 
five isotopes of concern used in conjunction with the anthropomorphic phantoms. 
 
Table 3.4.1 Selected isotopes and photon energies for use with anthropomorphic phantoms 
Isotope Photon Energy, MeV Photon Emission Intensity 
Am-241 
0.059, 0.026, 0.021, 0.0179, 0.0177, 
0.017, 0.0168, 0.0139, 0.0137 
0.357, 0.024, 0.045, 0.019, 0.188, 0.022, 
0.058, 0.219, 0.024 
Cs-137 0.662 0.853 
Co-60 1.332, 1.173 0.999, 0.999 
I-131 0.364, 0.637, 0.284, 0.723 0.812, 0.727, 0.606, 0.018 
Ir-192 
0.317, 0.468, 0.308, 0.296, 0.604, 0.612, 
0.589, 0.485 
0.828, 0.478, 0.297, 0.290, 0.0818, 0.0533, 
0.0452, 0.0316 
 
The detector was placed in four locations on the male phantom: front right lung, the back 
right lung, the front of the neck, and the outer left thigh.  The other four adult phantoms have 
significantly more breast tissue than the male phantom.  Thus, the front right lung position was 
excluded for these phantom types (due to the attenuation caused by breast tissue).  
Computer simulations were completed for each combination of phantom and isotope, 






Table 3.4.2 Anthropomorphic Phantom Simulations Completed 











Adipose Male Cs-137 
Adipose Male Co-60 
Adipose Male Am-241 
Adipose Male I-131 
Adipose Male Ir-192 
Adipose Female Cs-137 
Adipose Female Co-60 
Adipose Female Am-241 
Adipose Female I-131 
Adipose Female Ir-192 
Post Menopausal Adipose Female Cs-137 
Post Menopausal Adipose Female Co-60 
Post Menopausal Adipose Female Am-241 
Post Menopausal Adipose Female I-131 








3.5 Considerations of the Decision Level and Minimum Detectable Activity 
 The minimum detectable activity (MDA) for each isotope was considered to establish 
count rate thresholds for the thyroid uptake collimator.  First, a decision level (DL) is defined as 
the net count rate indicating the presence of radioactive material with some predetermined 









R +=   [Eqn 3.5.1] 
 In this expression,  
  Rb = background count rate 
  tb =  background counting time 
  tg = gross counting time 
The MDA is a value of activity that would result in a count rate less than the DL a certain 
fraction of the time.  This occurrence is a false negative, because there is actual activity present, 
but the system does not identify it based on the set decision level.  It is generally accepted to 










  µCiin MDA 
++
=    [Eqn 3.5.2] 
 In this expression,  
  K = counting yield, or counting efficiency.  
The MDA should not be compared to the measured count rate as it is a performance 
indicator for the counting system.  Instead, the determined DL should be compared to the count 
rate as an indicator for the presence of activity in the sample.  For this work, the calculated count 
rates were compared to the DL count rate for various counting times and background levels.  
These results are described in Chapter 6, Section 3.  
 
3.6 Considerations of the Minimum Detectable Dose 
 The minimum detectable dose (MDD) is a valuable quantity for bioassay applications.  
The MDD is directly proportional to the MDA and takes into account the biological half-life and 
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retention fraction of a particular isotope.  An expression for the MDD is shown in Equation 








=    [Eqn 3.6.1] 
 In this expression,  
YRC = radiochemical yield of the isotope of interest 
Vbio = biological variability in excretion rates and volumes 
IRFn = intake retention fraction, or the fraction of the intake that remains in any 
bioassay compartment 
∆t = time between intake and the bioassay measurement 
hE, 50 = 50-year committed effective dose per unit inhake (ICRP 1994) 
MDD values are not directly relevant to the intent of this work, therefore they were not 









 Computational models were developed to accurately represent the response of various 
detection systems to internal contamination in humans.  The Los Alamos Code, MCNP Version 
5 [45], was used to simulate the photon transport essential to replicating the response of the 
thyroid uptake collimator and detector.  The results of these simulations allow validation of the 
methodology by comparison with experimental measurements.  These computational models can 
also be used for comparison to other studies involving thyroid uptake counters.  A summary of 
the computational models used in this research is included below, including the use of various 
human phantoms internally contaminated with the five selected isotopes.     
 
4.1 Thyroid Uptake Collimator Model 
 The thyroid uptake collimator was modeled using the Los Alamos N-Particle Transport 
Code MCNP5. [45] Specifications from Capintec were used to model the critical components of 
the detector and collimator.  The NaI detector crystal was manufactured by Saint Gobain [35] 
and is surrounded by 0.508 mm of Aluminum.  The photomultiplier tube is mounted directly 
against the back of the crystal, and was represented by an enclosed cylindrical vacuum in the 
model.  A detector side shield (3.175 mm thick lead) wraps around the detector and connects to 
the collimator.  The 2” x 2” Ø NaI crystal and photomultiplier tube are housed in a lead and 
antimony collimator, which extends approximately 16 cm from the face of the crystal.  The 
entire collimator is enclosed in an outer steel layer that is painted.  The layer of paint was not 
included in the model.  A cross-sectional view generated with the VisEd program [46] of the 





Figure 4.1.1 (A) MCNP model of thyroid uptake collimator as displayed in VisEd;  
(B) Captus 3000 thyroid uptake collimator 
 
 The material compositions of the various components were either obtained from the 
Capintec drawings, or were selected based on industry standards.  The exact material 
compositions used in the thyroid uptake collimator model are shown in Table 4.1.1 and Table 
4.1.2. 
Table 4.1.1 Material composition of steel used in Thyroid Uptake Collimator model by atom fraction 
 Density Carbon Oxygen Phosphorus Manganese Iron 
AISI 1000 
[26] 
















Table 4.1.2 Material compositions of materials used in Thyroid Uptake Collimator model by atom fraction 
 Density Aluminum Copper Zinc Antimony Lead 
Brass 8.4 g/cc  0.65 0.35   
Antimonal 
Lead 
11.4 g/cc    0.04 0.96 
Lead 11.4 g/cc     1 
Aluminum 2.7 g/cc 1     
 
4.2 Slab Phantom Model 
The slab phantom was modeled in MCNP5 for the purpose of simulating the benchmark 
measurements made in the laboratory.  Variations of the slab phantom were created to represent 
each thickness of PMMA used in laboratory measurements.  The compositions of the PMMA 
and Virtual Water are shown in Table 4.2.1.   
Table 4.2.1 Material compositions of PMMA and Virtual Water by weight percent 
 Density Hydrogen Carbon Nitrogen Oxygen Chlorine Calcium 
PMMA [24] 1.19 g/cc 0.5333 0.3333  0.1333   
Virtual 
Water [43] 
1.03 g/cc 0.08056 0.6733 0.02149 0.2000 0.001406 0.02320 
 
Each source was modeled and placed at the same position in the PMMA source holder.  
The single isotope sources were fully encapsulated with activities ranging from 1.813x105 Bq to 
2.775x105 Bq.  Each source was approximately 2.3-cm in length and 0.4-cm in diameter.  Figure 




Figure 4.2.1 Cross-sectional VisEd representation of the slab phantom and thyroid uptake probe with source 
positioning. 
 
A pulse height tally (MCNP F8 tally) was performed over the NaI crystal volume for the 
photons (shown in Table 3.2.1) emitted by the sources.  MCNP tallies are normalized by the 
code to an emission of one source particle.  The tally output must then be multiplied by the exact 
activity of the laboratory source and branching ratios for a direct comparison.  For four of the 
isotopes used in the detector validation (Co-60, Am-241, Ba-133, Na-22), multiple gamma-rays 
are emitted for every particle disintegration.  In this case, the sum of the branching ratios (or the 
total number of photons emitted per decay) is used.  The branching ratios used are shown in 
Table 4.2.2. 
Table 4.2.2 Total branching ratio for each isotope used in slab phantom calculations 











A VisEd generated simulation of the emissions from the source and collisions in the 
surrounding materials as sampled in MCNP is shown in Figure 4.2.2. 
 
Figure 4.2.2 VisEd representation of the emissions from the source and collisions in surrounding materials 
 
 A Gaussian Energy Broadening (GEB) smoothing function available as an option in 
MCNP was used to simulate the detector resolution.  The GEB function is intended to provide a 
simple analytical function that represents the full width at half maximum of the physical detector 
to broaden the MCNP computed pulse-height spectrum to simulate the energy resolution of the 
detector.  In the raw MCNP tally, all photoelectric interactions lead to a single energy electron 
rather than a resolution broadened photopeak.  To illustrate the effect of the GEB smoothing 
function, a comparison of the raw MCNP tally, a GEB smoothed MCNP tally, and a measured 













































































Figure 4.2.3 Comparison of Measured Spectrum with Smoothed and Unsmoothed Calculated Spectra 
 
The parameters required for the GEB function (a, b, and c) were calculated based on the 
measured detector response for Co-60 (1.17 MeV and 1.33 MeV) and Na-22 (0.511 MeV).  The 
expression used to determine these three parameters is shown in Eqn 4.2.1 
2cEEbaFWHM ++=     [Eqn. 4.2.1] 
In this expression,  
 E = the energy of the particle 
FWHM = Full Width at Half Maximum for the photopeak   
The GEB parameters a, b, and c were determined iteratively using a fitting routine in 
Mathematica. [28] Figure 4.2.4 shows a plot of the detector resolution verse energy for the 
energies selected. 
Unsmoothed MCNP: 





























Figure 4.2.4: Detector resolution verse energy for the isotopes chosen to calculate the GEB parameters 
  
4.3 MIRD Phantom Models 
To simulate the response of the thyroid uptake collimator on internally contaminated 
individuals, a series of Monte Carlo models was used.  Six anthropomorphic phantoms, of 
varying ages and body sizes, were used in conjunction with the MCNP5 model of the thyroid 
uptake collimator.  These phantoms can be described by their height and body mass and the mass 
of adipose tissue.  The Body Mass Index (BMI) is a useful tool for characterizing human body 
size as well.  The BMI is calculated by dividing the mass (kg) by the square of the height (m), 
and is only valid for adults older than 17 years.  In general, a BMI greater than 30 indicates 














Reference Male 179 73.1 23 11 
Reference Female 168 56.5 20 15 
Adipose Male 179 93.7 30 22 
Adipose Female 168 73.9 26 15 
Post-Menopausal 
Adipose Female 
168 85.9 30 27 
10-year Androgynous 
Child 
140 32.7 n/a n/a 
  
The position of the thyroid uptake collimator can greatly influence the detection 
efficiency of internally deposited radionuclides.  Previous MCNP modeling studies showed that 
the back right lung and the front right lung are the most optimal chest locations for the thyroid 
uptake counter. [24] In our current model, the detector was placed at both the back right and 
front right chest positions for the male phantom, as well as on the outer left thigh and the front of 
the neck.  For each of the other phantom types, the front right chest position was excluded.  A 
VisEd generated representation of the male phantom with each of the thyroid uptake probe 




Figure 4.3.1 Thyroid uptake collimator positions on the Male anthropomorphic phantom 
 
A uniformly distributed unit source of each isotope of interest (Am-241, Cs-137, Co-60, 
I-131, and Ir-192) was distributed in various organs throughout the phantoms.  The organs 
selected are based on the ICRP models for inhaled dose, and include the gastro-intestinal tract 
and several body tissues.  These organs vary slightly depending on the gender of the phantom 
and the presence of adipose tissue.  The organs in which unit sources were distributed in the male 











Table 4.3.2 Organs where unit sources were distributed in MCNP model 
Isotope Organs 
Cs-137 
Left Lung, Right Lung, Stomach, Small Intestines, Heart, Ascending Colon 
Wall, Sigmoid Colon Wall, Transverse Colon Wall, Descending Colon Wall, 
Bladder, Body Tissue (Torso, Head, Shoulder, Left Leg, Right Leg, Genitalia) 
Co-60 
Left Lung, Right Lung, Stomach, Small Intestines, Heart, Ascending Colon 
Wall, Sigmoid Colon Wall, Transverse Colon Wall, Descending Colon Wall, 
Bladder, Body Tissue (Torso, Shoulder, Abdomen, Head, Left Leg, Right 
Leg, Genitalia), Liver 
I-131 
Left Lung, Right Lung, Stomach, Small Intestines, Heart, Ascending Colon 
Wall, Sigmoid Colon Wall, Transverse Colon Wall, Descending Colon Wall, 
Bladder, Body Tissue (Torso, Shoulder, Abdomen, Head, Left Leg, Right 
Leg, Genitalia), Thyroid 
Ir-192 
Left Lung, Right Lung, Stomach, Small Intestines, Heart, Ascending Colon 
Wall, Sigmoid Colon Wall, Transverse Colon Wall, Descending Colon Wall, 
Bladder, Body Tissue (Torso, Shoulder, Abdomen, Head, Left Leg, Right 
Leg, Genitalia), Liver, Left Kidney, Right Kidney, Spleen 
Am-241 
Left Lung, Right Lung, Stomach, Small Intestines, Heart, Ascending Colon 
Wall, Sigmoid Colon Wall, Transverse Colon Wall, Descending Colon Wall, 
Bladder, Body Tissue (Torso, Shoulder, Abdomen, Head, Right Leg, Left 
Leg), Liver, Ribs, Pelvis, Spine, Skull, Left Leg bones, Right Leg bones, Left 
Arm bones, Right Arm bones, Left Kidney, Right Kidney, Left Testicle, Right 
Testicle, Left Clavicle, Right Clavicle, Left Scapula, Right Scapula 
 
The difference between the organs in the male phantom and the female phantom is the 
addition of the right and left breast tissue included in the body tissue category.  Also, the female 
phantom includes the right and left ovaries rather than the testicles.  The adipose phantoms 
include the addition of adipose tissue on the abdomen, subcutaneous adipose tissue, and adipose 
tissue on the upper legs.  All adipose tissue is included in the body tissue grouping.  A unit 
source is distributed in the child phantom within the same organs as the male phantom. 
A source contribution tally modifier (SCX card) was used in conjunction with a pulse 
height tally (MCNP F8 tally) to determine the counts in the detector per a unit source distributed 
in each organ.  The tally modifier records the origin (in this case, the source organ) of each 
particle that reaches the detector.  This value is essentially the detector efficiency for a unit 
source in each organ for each isotope of concern. 
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Once the detector efficiency for each organ and each isotope has been computed using 
the MCNP model, these values were multiplied by the biokinetic modeling results.  The 
biokinetic modeling provides the fractional organ concentration as a function of time per 
becquerel of intake.  By summing the contributions from each source organ, the total count rate 
from the modeled detector was determined per becquerel of intake.   
As previously mentioned, count rates are reported per becquerel of intake and per 
Clinical Decision Level (CDL).   The MCNP input file for the male phantom with a unit source 









Biokinetic modeling describes the movement of a particular isotope through the human 
body as a function of time.  Depending on the characteristics of the isotope, it can concentrate in 
various organs or it can equally distribute itself throughout the body tissue.   
The Dose and Risk Calculation System (DCAL) software [9] was used to determine the 
movement of an isotope through the human body as a function of time.  Activity Calculations 
(ACTACAL) is part of the DCAL software, and it provides the activity as a function of time for 
various body compartments.  The DCAL biokinetic libraries include the ICRP-66 lung model 
[17]. the ICRP-30 gastro-intestinal tract model [12], and the ICRP-67 urinary bladder voiding 
model [16].  DCAL was originally created under the sponsorship of the Environmental 
Protection Agency (EPA) for estimating tissue dose and associated health risks associated with 
different environmental exposures. DCAL has been used in the development of several 
International Commission on Radiation Protection (ICRP) publications, in particular those with 
age-specific dose coefficients. [ICRP 1989, 1993, 1995a, 1995b, 1996] 
DCAL was used to estimate the retention fraction in affected organs as a function of time 
following initial uptake.  Six isotopes (Cs-137, Co-60, Am-241, I-131, Ir-192, and Sr/Y-90) were 
modeled using this method.  DCAL calls for several parameters in generating the compartmental 
activities.  For each isotope, inhalation was specified as the intake pathway, from an 
environmental source (as opposed to occupational), and activity median aerodynamic diameter 
(AMAD) of 1 micrometer was used.  The default lung absorption type (fast, moderate, or slow) 
was specified for each isotope according to the International Commission on Radiological 
 
28 
Protection (ICRP) recommended defaults. [21] These absorption types correspond broadly to the 
inhalation classes D, W, and Y from the ICRP Publication 30 model. [12] This classification 
refers to the length of time the radioactive materials are retained in the pulmonary region.  Class-
D materials have a ‘half-time’ in the lungs of less than 10 days, Class-W materials have a 
pulmonary half-time of 10 to 100 days, and Class-Y materials have a pulmonary half-time of 
greater than 100 days. [41] For the nuclides Cobalt and Americium, the ICRP default absorption 
type for particulate aerosol is moderate.  For Iodine and Cesium, the default type is fast.  A 
default type is not specified for Iridium, so moderate was selected.  The default types are 
summarized in Table 5.1.   












A comparison of the total fraction retained for each selected isotope for the first 30 days 
following intake is shown in Figure 5.1.   The retention of an isotope in the body is a function of 
both the clearance class, and the isotope’s radioactive half life.  As seen in the figure, Cs-137 has 





























Figure 5.1 Comparison of Total Fraction Retained for each selected isotope. 
 
DCAL shows that more than half of the initially inhaled activity is exhaled with the first 
breath for each of the isotopes with a moderate lung absorption class.  The main organs of 
interest for each isotope include the lungs, stomach, small and large intestines, and urinary 
bladder.  According to DCAL, these organs are of particular interest because large fractions of 
the amount originally inhaled move through the pulmonary tract and gastro-intestinal tract, 
depositing dose in these organs.  A large fraction is retained in the intestinal tract and body 
tissue.  The body tissue is composed of mostly abdominal tissue, but also includes breast tissue, 
adipose tissue, muscle tissue in the arms and legs, and genitalia.  As expected, certain isotopes 
collect in specific body tissues – an example is the collection of I-131 in the thyroid gland.  The 
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compartments retaining a significant fraction of the isotope were identified for each selected 
isotope using DCAL.  These compartments are shown in Table 5.2. 
 
Table 5.2 Body Compartments identified by DCAL for each selected isotope, bolded items are specific to that 
isotope 
Isotope Body Compartments identified by DCAL 
Cs-137 
Lungs, Stomach Content, Small Intestine Content, Upper Large 
Intestine Content, Lower Large Intestine Content, Blood, Body 
Tissue, Bladder Content 
Co-60 
Lungs, Stomach Content, Small Intestine Content, Upper Large 
Intestine Content, Lower Large Intestine Content, Blood, Body 
Tissue, Liver, Bladder Content 
I-131 
Lungs, Stomach Content, Small Intestine Content, Upper Large 
Intestine Content, Lower Large Intestine Content, Blood, Body 
Tissue, Thyroid, Bladder Content 
Ir-192 
Lungs, Stomach Content, Small Intestine Content, Upper Large 
Intestine Content, Lower Large Intestine Content, Blood, Body 
Tissue, Liver, Kidneys, Spleen, Bladder Content 
Am-241 
Lungs, Stomach Content, Small Intestine Content, Upper Large 
Intestine Content, Lower Large Intestine Content, Blood, Body 
Tissue, Cortical Bone, Trabecular Bone, Liver, Kidneys, 
Testes/Ovaries, Red Marrow, Bladder Content 
Sr/Y-90 
Lungs, Stomach Content, Small Intestine Content, Upper Large 
Intestine Content, Lower Large Intestine Content, Blood, Body 
Tissue, Cortical Bone, Trabecular Bone, Bladder Content 
 
A graphical comparison of the lungs, body tissue, and any special organs for each isotope 
is shown in Figures 5.2 through 5.7.  The lungs and body tissue were selected due to the high 
fraction retained in each of these body compartments.  The total retention fraction is also 


































Isotope Retention in Lungs
Isotope Retention in Body Tissue
 





























Isotope Retention in Lungs
Isotope Retention in Body Tissue
Isotope Retention in Liver
 
Figure 5.3 Retention of Co-60 (moderate)in the lungs, body tissue, and liver and total fraction retained over 


































Isotope Retention in Lungs
Isotope Retention in Body Tissue
Isotope Retention in Thyroid
 
Figure 5.4 Retention of I-131 (fast) in the lungs, body tissue, and thyroid and total fraction retained over first 
































Isotope Retention in Lungs
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Isotope Retention in Liver
Isotope Retention in Kidneys
Isotope Retention in Spleen
 
Figure 5.5 Retention of Ir-192 (moderate) in the lungs, body tissue, liver, kidneys, and spleen and total 


































Isotope Retention in Lungs
Isotope Retention in Body Tissue
Isotope Retention in Liver
Isotope Retention in Kidneys
Isotope Retention in Bone, Including Marrow
 
Figure 5.6 Retention of Am-241 (moderate) in the lungs, body tissue, liver, kidneys, and bone (including red 
































Isotope Retention in Lungs
Isotope Retention in Body Tissue
Isotope Retention in Bone
 
Figure 5.7 Retention of Sr/Y-90 (moderate) in the lungs, body tissue, and bone and total fraction retained 




A fundamental component in assaying internal contamination is understanding the 
movement of an isotope through the body.  Accordingly, the DCAL predicted organ activities are 
folded with the detector response for each organ and summed for each detector location.  The 
convolution provides count rates for each detector location per unit of inhaled activity as a 









6.1 Model Validation 
The MCNP model of the thyroid uptake collimator was validated in a comparison 
between the measured data and the MCNP calculated data.  The measured slab phantom spectra 
for the six isotopes described in Table 3.2.1 were compared to the MCNP model prediction to 
check the representation of the actual detector response over a broad gamma-ray energy range.  
Both the total spectra and the selected Regions of Interest (ROI) around each photopeak were 
examined.  This process was also used to create a scaling factor between the measured and 
calculated spectra, if needed.  A representative comparison between the measured and calculated 
spectra for each measured isotope is shown in Figures 6.1.1 through 6.1.6.  These spectra were 
measured with a thickness of 60mm of PMMA between the collimator and the source.  Spectra 







































































































































































































































Figure 6.1.6 Measured and calculated spectra for Na-22 with 60 mm PMMA 
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The gamma-ray photopeaks for the benchmark measurements were automatically 
selected using the thyroid uptake system nuclide identification software.  The default calibration 
is set to 2keV/channel, and the nuclide selection tool calls upon preset values in the data library 
for each isotope.  For consistency, the same ROI was used for the calculated spectra.  The default 
ROI values for each isotope are shown in Table 6.1.1. 
Table 6.1.1: Capintec default ROI values used in measured and calculated spectra 
Isotope Default ROI (keV) 
Am-241 49-70 




Na-22 480-546, 1220-1328 
 
The ratio of the calculated (MCNP) count rate to the measured count rate for the gamma-
ray photopeak(s) of each isotope are shown in Figures 6.1.7 through 6.1.12.  The solid line in 
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Figure 6.1.8 Ratio of MCNP results to measured data for the sum of the 1.17 and 1.33 MeV photopeaks from 
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Figure 6.1.9 Ratio of MCNP results to measured data for the sum of the 0.511 and 1.27 MeV photopeaks from 
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Figure 6.1.11 Ratio of MCNP results to measured data for the sum of the 31, 80, and 356 keV photopeaks 














0 6 12 18 24 30 36 42 48 54 60 66 72 78 84 90 96 102 108
Thickness of PMMA
 




As seen in the figures, the ratio of the calculated spectra to measured spectra is essentially 
constant over all thicknesses for a given isotope.  This indicates that the model of the detector is 
valid regardless of the attenuator thickness.  This result provides confidence when using the 
detector in conjunction with the anthropomorphic phantoms. Any differences in chest-wall 
thickness between the various phantoms will not affect the detector response in the photopeaks, 
nor should it. 
Ideally, the ratio of the calculated spectra to the measured photopeaks would be one.  In 
actuality, a number of factors introduce error terms into the data.  The error on each photopeak is 
dominated by the reported source activity error of 3.3%.  The pulse-height bin error from MCNP 
and the counting error from the measured spectra were considerably smaller than the source 
activity error, but were also considered and included in the error calculations, illustrated by the 
error bars.  All data for each isotope fall within 2 standard deviations of the mean. 
To compensate for the differences between the measured and calculated spectra, a scaling 
factor (the mean ratio) is applied to the phantom results.  This ‘converts’ the measured pulse-
height tally to an equivalent count rate on the actual probe.  The scaling factors for each isotope 
that is used for both benchmark measurements and phantom calculations are shown in Table 
6.1.2.  
Table 6.1.2 Scaling Factors for isotopes used in benchmark measurements and phantom calculations 





The ratios for Ba-133 and Am-241 show a negative slope as the thickness of PMMA 
increases.  The most probable cause for this is an inappropriate representation of the resolution 
by the GEB function at these energies.  The lowest energy considered in determining the GEB 
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function was 0.511 MeV (Na-22).  Ba-133 and Am-241 both have gamma-ray emissions at 
energies lower than 0.511 MeV meaning that they have a higher resolution.  This is due to the 
fact that resolution is inversely proportional to the square-root of the gamma ray energy. [Knoll, 
2002] A comparison of the spectra shows that indeed, the calculated ROIs are considerably 
broader than the measured spectra.  This can be seen in the Slab Phantom Spectral Data, 
contained in Appendix B. 
 With the exception of Am-241, all the isotopes of greatest concern investigated herein 
have energies higher than 300 keV.  Thus, the GEB function is adequate for the purpose and 
intent of this work and therefore the scaling factor also is valid.  The scaling factor corrects for 
differences between the measured and calculated data, and provides a validated estimate of the 
actual detector response. 
 
6.2 MIRD Phantom Results 
 In the event of an actual emergency requiring the use of this screening procedure, the 
operators are not expected to visually inspect the spectra to select an optimal ROI.  Instead, they 
will simply use the Capintec nuclide identification tool, which selects the ROI channels based on 
data stored in the Captus 3000 data library.  Thus, the following results use the scaling factor 
based on the Captus system default ROI selection, which was discussed in the previous section.  
Two of the isotopes (I-131 and Ir-192) used in the phantom simulations were not included in the 
benchmark measurements and validation process.  As a result, scaling factors were not calculated 
for these two isotopes; Capintec system default ROIs were used throughout the analysis for these 
two isotopes. 
Each of the six isotopes listed in Table 3.4.1 were uniformly distributed in the six 
phantom types.  The results for the Male phantom contaminated with Cs-137 are shown in Table 
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6.2.1.  The values are given in count rate (counts per minute) per becquerel of intake activity.  
Results for the remaining phantom types contaminated with Cs-137 and each of the other four 
isotopes are provided in Appendix D.  
Table 6.2.1 Count rate per Bq calculated for the Male phantom contaminated with Cs-137 
Back Right Lung 
Front Right 
Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq cpm per Bq 
0 1.85E-04 1.77E-04 1.51E-05 1.31E-06 
1 4.29E-04 4.63E-04 5.07E-04 2.47E-04 
2 4.11E-04 4.48E-04 5.20E-04 2.54E-04 
3 3.94E-04 4.30E-04 5.08E-04 2.49E-04 
4 3.83E-04 4.19E-04 4.99E-04 2.44E-04 
5 3.76E-04 4.11E-04 4.91E-04 2.40E-04 
6 3.71E-04 4.05E-04 4.84E-04 2.37E-04 
7 3.66E-04 4.00E-04 4.79E-04 2.35E-04 
8 3.63E-04 3.97E-04 4.74E-04 2.32E-04 
9 3.60E-04 3.93E-04 4.70E-04 2.30E-04 
10 3.57E-04 3.90E-04 4.66E-04 2.28E-04 


















30 3.13E-04 3.42E-04 4.09E-04 2.00E-04 
 
As discussed, the fast absorption type of Cs-137 rapidly distributes itself through the 
body tissue and is quickly out of the lung cavities.  Analysis of the data for Cs-137 shows that 
after one day, the neck provides a higher count rate per becquerel than the front and back lung 
positions.  The thigh shows a lower count rate; however, it is the same order of magnitude as the 
lung and neck count rates. 
In the case of Cs-137, the variability between body type and detector response is much 
more pronounced than for the other isotopes.  Figure 6.2.1 shows a graphical comparison of the 
count rates resulting from each phantom type contaminated with Cs-137 with the detector on the 
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neck.  The other detector positions (back right lung and thigh) show a similar distribution, with a 
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Figure 6.2.1 Comparison of count rate per phantom type for Cs-137, with detector positioned on the neck 
 
An analysis of the various phantom results shows that in general, the highest count rate is 
found in the child.  This is expected as the child has the least amount of tissue, or attenuating 
material, between the isotope and the detector.  The lowest count rate is found in one of the 
adipose phantoms, usually the Post-Menopausal Adipose Female.  The Post-Menopausal 
Adipose Female has more tissue, resulting in more attenuation and absorption of the gamma ray 
photons before they reach the detector crystal.  While it is tempting to make such generalities 
about the effects of body type on the detector response, in actuality the isotope has just as much 
impact on the count rate.   
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For the case of I-131, the count rates are more similar between the phantom types, and in 
fact, the child shows the lowest count rate per becquerel.  As discussed, I-131 is rapidly absorbed 
by the thyroid gland.  A child has a smaller thyroid gland than an adult, causing it to become 
saturated with I-131 before an adult’s thyroid. [42] Figure 6.2.2 shows the increasing count rate 
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Figure 6.2.2 Count Rate per Bq of intake of I-131 for the neck position  
 
A large fraction of Co-60 intake remains in the lungs, and this is reflected in the higher 
count rate found at the back right lung position of the detector.  In addition, there is little 
variation between phantom types for Co-60.  The Reference Male and Reference Female 
phantoms have similar response, as do the adipose phantoms.  A comparison of the detector 









































Figure 6.2.3 Comparison of detector position and phantom type for Co-60, 3 days after intake 
 
 
 Ir-192 is similar to Co-60 in that they both have moderate lung absorption types; 
consequently, the most efficient measurement location is the back right lung for each phantom 
type.  A significant portion of the uptake of Ir-192 goes to the blood and as a result, the majority 
of the counts originate in the liver, heart, and body tissue.  The count rate as a function of time 
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Figure 6.2.4 Count rate as a function of time for each phantom type contaminated with Ir-192 
 
The effects of body type on the detector response are also similar between Co-60 and Ir-
192.  Similar phantom types display similar count rates: the adipose phantoms show the lowest 
count rate, but there is little variability between each adipose phantom.  The reference male and 
reference female show similar count rates.  Also, as seen in Cs-137 and Co-60, the highest count 
rate for Ir-192 was exhibited in the child phantom. 
Am-241 showed the lowest count rate per Bq of activity.  Due to the low energy of the 
gamma-ray emission (59.5keV) only a small fraction of the particles travel to the detector.  Due 
to this, the count rate per Bq is several orders of magnitude less than the other isotopes.  In 
addition, the dose coefficient for Am-241 is much lower than the other isotopes investigated in 
this work.  As a result, the count rate due to an intake of Am-241 that would result in a 25 rem 
committed effective dose by inhalation is less than one count per minute for the male phantom 
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for the back lung position and less than 0.01 counts per minute for the neck and thigh position in 
the male phantom for all times modeled. 
The statistical error of the computational models was the main source of error for each of 
the phantom results.  The total bin error for each tally was generally less than 1%. 
Monte Carlo simulations were also performed using Strontium-90 and the male phantom 
type.  Strontuim-90 emits a beta spectrum with an average beta energy of 934 keV and exists in 
secular equilibrium with Yttrium-90 which emits a beta spectrum with an average beta energy of 
196 keV. [8] Electrons were generated in the source organs, and were also transported in the 
model.  Bremmsstrahlung photons were also generated and tracked, and both electrons and 
photons were tallied in the detector crystal.  The results of the simulation showed that the thyroid 
uptake collimator was unable to detect significant amounts of Sr/Y-90, and on the basis of these 
results the other phantom types were not simulated. 
 
6.3 Consideration of Background Spectra 
 Thyroid Uptake Systems are built with collimators for the purpose of shielding 
background and obtaining a spectrum from a fairly localized area.  In the event of a RDD, there 
could be widespread contamination surrounding the measurement areas.  In an emergency 
situation, it is possible, though not likely, that external contamination may still be present on the 
skin or clothing of individuals being assessed.  In this case, the collimator provides a basic 
advantage by attenuating a significant amount of radiation emitted from external contamination.  
For this work, external contamination on the victims was not considered and not included in the 
phantom models.  The only source of background is assumed to originate from the surroundings, 
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not the individual.  To thoroughly understand the effect that high background rates might have 
on assessing internal contamination, the following analysis was performed.  
Several background measurements were collected at the Emory University Hospital 
Nuclear Medicine Injection Room in Atlanta, Georgia.  In this room, nuclear medicine 
procedures involving various isotopes are conducted.  The room has a relatively high background 
rate since contaminated objects (needles, towels, gloves, etc) are disposed of in a lead shielded 
box stored in the room.  A Captus 2000 Thyroid Uptake System was housed in this room, and 
background count rate levels were collected using this machine.  The Captus 2000 and the 
Captus 3000 are very similar in that each includes a thyroid uptake collimator with a 2” by 2” 
NaI crystal and a lead and antimony collimator.  One major difference between the two systems 
is that the Captus 2000 does not include the nuclide identification tool.  As a result, background 
rates were collected for the entire spectrum only. 
 The average background rate in this room was 2846 counts per minute.  Counts were 
taken for 10 minutes of live time.  In the Georgia Tech laboratory that held the Captus 3000 
Thyroid Uptake System, the background rate was significantly lower.  The average background 
rate was approximately 1700 counts per minute, recorded over 10 minutes of live time.  One 
background spectrum collected in the Georgia Tech laboratory is shown in Figure 6.3.1.  The 
spectrum has been scaled up by a factor of two to approximate a more realistic hospital 

























Figure 6.3.1 Background spectrum collected at Georgia Tech laboratory 
 
 
6.4 Decision Levels 
 The DL for determining whether activity is present was calculated for the thyroid uptake 
collimator.  The DL is a function of the background rate and counting times; thus is is dependent 
on the isotope.  The background rate in the Capintec ROI was used for each isotope.  The DL 
values represent the minimum count rates above background to assume that activity is present.  
Table 6.4.1 shows the DL necessary for a one minute counting time for a factor of five times the 
scaled up Georgia Tech background spectrum (this is essentially 10 times the average 
background count rate).  This table also includes the default ROI values for each isotope used in 





Table 6.4.1 Decision Levels for one minute counting times for the thyroid uptake collimator 
Isotope Default ROI (keV) 
5 x background count 
rate in ROI 
Decision Level for 
one minute counting 
time 
(Count rate above 
background) 
Am-241 49-70 5340 40 
Cs-137 627-697 6430 44 
Co-60 1126-1382 5120 39 
Ir-192 287-335 9230 52 




 As anticipated, the minimum count rate required to determine the presence of activity 
with 95% confidence increases as the background rate increases, and decreases as counting time 
increases.  In the event of an RDD, the minimum counting time will be desired to maximize the 
number of people assessed in a given amount of time.  By comparing the decision level to the 
calculated count rate due to an intake of one CDL for the male phantom, it has been determined 
that one minute is more than adequate to detect Cs-137, Co-60, or Ir-192 from the back right 
lung position.   I-131 can be detected from the back right lung position with a one minute 
counting time for the first two days following intake.  Subsequent to that, the neck is a more 
optimal position.  If the detector is placed over the neck, a one minute counting time is sufficient 
to detect one CDL of Cs-137 and I-131 as well.  The thigh is not an adequate position for 
assaying I-131 or Am-241.  For Co-60, Cs-137, and Ir-192, a one minute counting time is 
sufficient to detect an intake of one CDL or greater for the thigh position.  Am-241 is not 
detectable above background at any of the studied detector positions.  A comparison of the count 
rate per CDL and the DL for a one minute counting time is shown in Table 6.4.2 for each isotope 
and the optimal detector position.  From this comparison, it is clear that Am-241 is undetectable, 




Table 6.4.2 Count rate per CDL for optimal detector position on male phantom, 3 days following initial intake 
Isotope Detector Position 
Count Rate (cpm) 
per CDL 
Decision Level for 
one minute counting 
time 
(Count rate above 
background) 
Am-241 Back Right Lung 0.146 40 
Cs-137 Neck 27600 44 
Co-60 Back Right Lung 2390 39 
Ir-192 Back Right Lung 4670 52 
I-131 Neck 2530 50 
 
With 27 kg of adipose tissue, the Post-Menopausal Adipose Female phantom contains the 
most adipose tissue, and as a result generally shows the lowest count rates per Bq of intake.  By 
examining the Post-Menopausal Adipose Female, an upper limit to the minimum necessary 
counting time can be estimated.  A counting time of one minute is sufficient to detect one CDL 
of Co-60, Ir-192, and Cs-137 when the detector is placed over the back right lung.  For I-131 and 
Cs-137, the detector should be placed over the front neck to achieve maximum efficiency.  One 
minute is a sufficient amount of time to detect I-131 and Cs-137 when the detector is placed on 
the front neck of the Post-Menopausal Adipose Female phantom.   
 
6.5 Personal Contamination Screening Threshold Determination 
As previously discussed, one Clinical Decision Level is assumed to be an intake which 
leads to 25 rem committed effective dose.  The actual use of the Clinical Decision Level will be 
made by governing bodies at the time of an event.  The dose coefficients for inhalation for each 
isotope are from ICRP 72 and were determined using Rad Toolbox [8].  The dose coefficients 










10 year Child 
(Bq/CDL) 
Cs-137 F 5.43E+07 1.25E+08 
Co-60 M 2.50E+07 1.67E+07 
I-131 F 3.38E+07 1.32E+07 
Ir-192 M 4.81E+07 3.29E+07 
Am-241 M 5.95E+03 6.25E+03 
 
Count rates per CDL are given for each isotope and phantom type in Tables 6.5.2 through 
6.5.31. 
Table 6.5.2 Count rate per CDL for the Male phantom contaminated with Cs-137 
Back Right Lung Front Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL cpm per CDL 
0 1.01E+04 9.65E+03 8.20E+02 7.11E+01 
1 2.33E+04 2.52E+04 2.76E+04 1.34E+04 
2 2.24E+04 2.43E+04 2.82E+04 1.38E+04 
3 2.14E+04 2.34E+04 2.76E+04 1.35E+04 
4 2.08E+04 2.27E+04 2.71E+04 1.33E+04 
5 2.04E+04 2.23E+04 2.67E+04 1.31E+04 
6 2.01E+04 2.20E+04 2.63E+04 1.29E+04 
7 1.99E+04 2.18E+04 2.60E+04 1.27E+04 
8 1.97E+04 2.16E+04 2.58E+04 1.26E+04 
9 1.95E+04 2.14E+04 2.56E+04 1.25E+04 
10 1.94E+04 2.12E+04 2.54E+04 1.24E+04 



































Table 6.5.3 Count rate per CDL for the Female phantom contaminated with Cs-137 
Back Right Lung Neck Thigh   
  cpm per CDL cpm per CDL cpm per CDL 
0 9.38E+03 8.10E+02 8.62E+01 
1 2.94E+04 3.47E+04 1.29E+04 
2 2.87E+04 3.56E+04 1.32E+04 
3 2.77E+04 3.49E+04 1.30E+04 
4 2.70E+04 3.42E+04 1.27E+04 
5 2.65E+04 3.37E+04 1.25E+04 
6 2.62E+04 3.32E+04 1.24E+04 
7 2.59E+04 3.29E+04 1.22E+04 
8 2.56E+04 3.26E+04 1.21E+04 
9 2.54E+04 3.23E+04 1.20E+04 
10 2.52E+04 3.20E+04 1.19E+04 






















Table 6.5.4 Count rate per CDL for the Adipose Male phantom contaminated with Cs-137 
Back Right Lung Neck Thigh   
  cpm per CDL cpm per CDL cpm per CDL 
0 6.64E+03 5.59E+02 3.49E+01 
1 2.00E+04 3.15E+04 1.25E+04 
2 1.95E+04 3.24E+04 1.28E+04 
3 1.88E+04 3.17E+04 1.26E+04 
4 1.83E+04 3.11E+04 1.23E+04 
5 1.80E+04 3.06E+04 1.21E+04 
6 1.77E+04 3.02E+04 1.20E+04 
7 1.75E+04 2.99E+04 1.19E+04 
8 1.73E+04 2.96E+04 1.17E+04 
9 1.72E+04 2.94E+04 1.16E+04 
10 1.70E+04 2.91E+04 1.15E+04 





























Table 6.5.5 Count rate per CDL for the Adipose Female phantom contaminated with Cs-137 
Back Right Lung Neck Thigh  
  cpm per CDL cpm per CDL cpm per CDL 
0 7.00E+03 6.21E+02 5.13E+01 
1 2.29E+04 3.06E+04 1.79E+04 
2 2.24E+04 3.14E+04 1.85E+04 
3 2.16E+04 3.07E+04 1.81E+04 
4 2.11E+04 3.01E+04 1.77E+04 
5 2.07E+04 2.97E+04 1.75E+04 
6 2.04E+04 2.93E+04 1.72E+04 
7 2.02E+04 2.90E+04 1.71E+04 
8 2.00E+04 2.87E+04 1.69E+04 
9 1.98E+04 2.84E+04 1.67E+04 
10 1.96E+04 2.82E+04 1.66E+04 






















Table 6.5.6 Count rate per CDL for the Post-Menopausal Adipose Female phantom contaminated with Cs-137 
Back Right Lung Neck Thigh   
  cpm per CDL cpm per CDL cpm per CDL 
0 1.14E+03 4.12E+02 4.57E+01 
1 5.98E+03 8.43E+03 3.01E+03 
2 5.97E+03 8.61E+03 3.09E+03 
3 5.79E+03 8.42E+03 3.03E+03 
4 5.66E+03 8.25E+03 2.97E+03 
5 5.56E+03 8.12E+03 2.92E+03 
6 5.49E+03 8.02E+03 2.88E+03 
7 5.43E+03 7.93E+03 2.85E+03 
8 5.37E+03 7.85E+03 2.82E+03 
9 5.33E+03 7.78E+03 2.80E+03 
10 5.28E+03 7.72E+03 2.78E+03 





























Table 6.5.7 Count rate per CDL for the Child phantom contaminated with Cs-137 
Back Right Lung Neck Thigh   
  cpm per CDL cpm per CDL cpm per CDL 
0 2.85E+04 2.37E+03 0.00E+00 
1 8.75E+04 9.29E+04 4.83E+04 
2 8.53E+04 9.52E+04 4.98E+04 
3 8.21E+04 9.32E+04 4.88E+04 
4 8.01E+04 9.14E+04 4.79E+04 
5 7.87E+04 9.00E+04 4.71E+04 
6 7.76E+04 8.88E+04 4.65E+04 
7 7.67E+04 8.78E+04 4.60E+04 
8 7.59E+04 8.70E+04 4.56E+04 
9 7.53E+04 8.62E+04 4.52E+04 
10 7.47E+04 8.55E+04 4.48E+04 






















Table 6.5.8 Count rate per CDL calculated for the Male phantom contaminated with Co-60 
Back Right Lung Front Right Lung Neck Thigh   
  cpm per CDL cpm per CDL cpm per CDL cpm per CDL 
0 6.91E+03 6.63E+03 1.60E+03 1.64E+02 
1 3.24E+03 3.32E+03 1.31E+03 5.09E+02 
2 2.66E+03 2.69E+03 1.21E+03 5.04E+02 
3 2.39E+03 2.41E+03 1.13E+03 4.59E+02 
4 2.26E+03 2.27E+03 1.08E+03 4.25E+02 
5 2.18E+03 2.19E+03 1.03E+03 4.01E+02 
6 2.12E+03 2.13E+03 9.98E+02 3.83E+02 
7 2.08E+03 2.08E+03 9.69E+02 3.69E+02 
8 2.03E+03 2.04E+03 9.43E+02 3.57E+02 
9 2.00E+03 2.00E+03 9.19E+02 3.47E+02 
10 1.96E+03 1.96E+03 8.98E+02 3.37E+02 




























Table 6.5.9 Count rate per CDL calculated for the Female phantom contaminated with Co-60 
Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 6.59E+03 1.61E+03 1.92E+02 
1 3.21E+03 1.58E+03 5.21E+02 
2 2.69E+03 1.52E+03 5.10E+02 
3 2.44E+03 1.44E+03 4.62E+02 
4 2.31E+03 1.37E+03 4.27E+02 
5 2.23E+03 1.32E+03 4.03E+02 
6 2.17E+03 1.27E+03 3.85E+02 
7 2.12E+03 1.23E+03 3.71E+02 
8 2.08E+03 1.20E+03 3.59E+02 
9 2.04E+03 1.17E+03 3.49E+02 
10 2.00E+03 1.14E+03 3.39E+02 






















Table 6.5.10 Count rate per CDL calculated for the Adipose Male phantom contaminated with Co-60 
Back Right Lung Neck Thigh   
cpm per CDL cpm per CDL cpm per CDL 
0 4.79E+03 1.18E+03 9.96E+01 
1 2.32E+03 1.28E+03 4.53E+02 
2 1.95E+03 1.28E+03 4.63E+02 
3 1.78E+03 1.22E+03 4.28E+02 
4 1.68E+03 1.17E+03 3.98E+02 
5 1.62E+03 1.12E+03 3.77E+02 
6 1.58E+03 1.08E+03 3.61E+02 
7 1.54E+03 1.05E+03 3.47E+02 
8 1.51E+03 1.02E+03 3.36E+02 
9 1.48E+03 9.93E+02 3.25E+02 
10 1.46E+03 9.68E+02 3.17E+02 




























Table 6.5.11Count rate per CDL calculated for the Adipose Female phantom contaminated with Co-60 
Back Right Lung Neck Thigh   
cpm per CDL cpm per CDL cpm per CDL 
0 4.95E+03 1.27E+03 1.29E+02 
1 2.48E+03 1.31E+03 5.58E+02 
2 2.10E+03 1.30E+03 5.93E+02 
3 1.91E+03 1.24E+03 5.63E+02 
4 1.81E+03 1.18E+03 5.31E+02 
5 1.74E+03 1.13E+03 5.06E+02 
6 1.70E+03 1.10E+03 4.85E+02 
7 1.66E+03 1.06E+03 4.67E+02 
8 1.62E+03 1.03E+03 4.52E+02 
9 1.59E+03 1.00E+03 4.38E+02 
10 1.56E+03 9.79E+02 4.26E+02 






















Table 6.5.12 Count rate per CDL calculated for the Post-Menopausal Adipose Female phantom contaminated 
with Co-60 
Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 5.07E+03 1.33E+03 1.24E+02 
1 2.47E+03 1.40E+03 3.98E+02 
2 2.07E+03 1.40E+03 3.96E+02 
3 1.88E+03 1.34E+03 3.61E+02 
4 1.78E+03 1.28E+03 3.35E+02 
5 1.72E+03 1.23E+03 3.17E+02 
6 1.67E+03 1.18E+03 3.03E+02 
7 1.63E+03 1.15E+03 2.92E+02 
8 1.60E+03 1.11E+03 2.82E+02 
9 1.57E+03 1.08E+03 2.74E+02 
10 1.54E+03 1.06E+03 2.66E+02 



























Table 6.5.13 Count rate per CDL calculated for the Child phantom contaminated with Co-60 
Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 5.60E+03 1.11E+03 3.19E+02 
1 2.75E+03 1.22E+03 5.00E+02 
2 2.30E+03 1.16E+03 4.59E+02 
3 2.08E+03 1.09E+03 4.07E+02 
4 1.97E+03 1.03E+03 3.74E+02 
5 1.90E+03 9.88E+02 3.52E+02 
6 1.85E+03 9.53E+02 3.37E+02 
7 1.81E+03 9.23E+02 3.26E+02 
8 1.77E+03 8.96E+02 3.16E+02 
9 1.73E+03 8.72E+02 3.07E+02 
10 1.70E+03 8.51E+02 2.99E+02 






















Table 6.5.14 Count rate per CDL calculated for the Male phantom contaminated with Am-241 
Back Right Lung Front Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL cpm per CDL 
0 4.26E-01 4.07E-01 2.83E-03 0.00E+00 
1 1.90E-01 1.54E-01 8.60E-03 3.86E-03 
2 1.58E-01 1.21E-01 6.05E-03 2.63E-03 
3 1.46E-01 1.08E-01 5.10E-03 1.99E-03 
4 1.42E-01 1.03E-01 4.76E-03 1.73E-03 
5 1.40E-01 1.00E-01 4.65E-03 1.63E-03 
6 1.39E-01 9.85E-02 4.63E-03 1.61E-03 
7 1.38E-01 9.72E-02 4.64E-03 1.61E-03 
8 1.38E-01 9.60E-02 4.66E-03 1.62E-03 
9 1.38E-01 9.49E-02 4.69E-03 1.63E-03 
10 1.37E-01 9.39E-02 4.71E-03 1.64E-03 




























Table 6.5.15 Count rate per CDL calculated for the Female phantom contaminated with Am-241 
Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 3.87E-01 3.36E-03 0.00E+00 
1 1.95E-01 9.10E-03 4.16E-03 
2 1.68E-01 6.41E-03 2.83E-03 
3 1.59E-01 5.41E-03 2.10E-03 
4 1.56E-01 5.05E-03 1.80E-03 
5 1.55E-01 4.93E-03 1.69E-03 
6 1.54E-01 4.91E-03 1.66E-03 
7 1.55E-01 4.92E-03 1.65E-03 
8 1.55E-01 4.94E-03 1.66E-03 
9 1.55E-01 4.97E-03 1.67E-03 
10 1.55E-01 4.99E-03 1.69E-03 






















Table 6.5.16 Count rate per CDL calculated for the Adipose Male phantom contaminated with Am-241 
Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 2.47E-01 2.69E-03 2.69E-03 
1 1.25E-01 8.20E-03 8.20E-03 
2 1.08E-01 5.77E-03 5.77E-03 
3 1.02E-01 4.86E-03 4.86E-03 
4 1.00E-01 4.54E-03 4.54E-03 
5 9.95E-02 4.43E-03 4.43E-03 
6 9.94E-02 4.41E-03 4.41E-03 
7 9.95E-02 4.42E-03 4.42E-03 
8 9.96E-02 4.44E-03 4.44E-03 
9 9.98E-02 4.47E-03 4.47E-03 
10 1.00E-01 4.49E-03 4.49E-03 




























Table 6.5.17 Count rate per CDL calculated for the Adipose Female phantom contaminated with Am-241 
Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 3.06E-01 3.13E-03 7.94E-06 
1 1.52E-01 8.49E-03 6.94E-03 
2 1.31E-01 5.98E-03 4.77E-03 
3 1.23E-01 5.05E-03 3.80E-03 
4 1.20E-01 4.71E-03 3.43E-03 
5 1.20E-01 4.60E-03 3.30E-03 
6 1.19E-01 4.58E-03 3.27E-03 
7 1.19E-01 4.59E-03 3.28E-03 
8 1.19E-01 4.61E-03 3.30E-03 
9 1.19E-01 4.63E-03 3.33E-03 
10 1.20E-01 4.66E-03 3.36E-03 






















Table 6.5.18 Count rate per CDL calculated for the Post-Menopausal Adipose Female phantom contaminated 
with Am-241 
 Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 2.67E-01 3.41E-03 0.00E+00 
1 1.36E-01 8.98E-03 3.14E-03 
2 1.18E-01 6.33E-03 2.14E-03 
3 1.12E-01 5.35E-03 1.59E-03 
4 1.10E-01 4.99E-03 1.35E-03 
5 1.09E-01 4.87E-03 1.27E-03 
6 1.09E-01 4.85E-03 1.24E-03 
7 1.09E-01 4.86E-03 1.24E-03 
8 1.09E-01 4.88E-03 1.25E-03 
9 1.09E-01 4.90E-03 1.26E-03 
10 1.09E-01 4.93E-03 1.27E-03 




























Table 6.5.19 Count rate per CDL calculated for the Child phantom contaminated with Am-241 
Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 6.92E-01 1.17E-02 0.00E+00 
1 3.14E-01 2.12E-02 7.19E-03 
2 2.61E-01 1.51E-02 4.71E-03 
3 2.42E-01 1.28E-02 3.23E-03 
4 2.34E-01 1.19E-02 2.59E-03 
5 2.31E-01 1.17E-02 2.35E-03 
6 2.29E-01 1.16E-02 2.27E-03 
7 2.29E-01 1.16E-02 2.25E-03 
8 2.28E-01 1.16E-02 2.26E-03 
9 2.27E-01 1.17E-02 2.27E-03 
10 2.27E-01 1.17E-02 2.29E-03 






















Table 6.5.20 Count rate per CDL calculated for the Male phantom contaminated with I-131 
Back Right Lung Front Right Lung Neck Thigh   
 cpm per CDL cpm per CDL cpm per CDL cpm per CDL 
0 9.67E+03 9.28E+03 8.16E+01 6.41E+00 
1 1.13E+03 1.11E+03 2.91E+03 3.45E+01 
2 3.76E+02 3.91E+02 2.75E+03 2.07E+01 
3 1.58E+02 1.81E+02 2.53E+03 2.73E+01 
4 9.16E+01 1.15E+02 2.32E+03 3.32E+01 
5 7.25E+01 9.53E+01 2.12E+03 3.76E+01 
6 6.82E+01 8.96E+01 1.95E+03 4.06E+01 
7 6.80E+01 8.79E+01 1.78E+03 4.25E+01 
8 6.83E+01 8.67E+01 1.63E+03 4.34E+01 
9 6.82E+01 8.51E+01 1.49E+03 4.37E+01 
10 6.74E+01 8.30E+01 1.37E+03 4.33E+01 




























Table 6.5.21 Count rate per CDL calculated for the Female phantom contaminated with I-131 
Back Right Lung Neck Thigh   
 cpm per CDL cpm per CDL cpm per CDL 
0 8.98E+03 8.03E+01 8.48E+00 
1 1.07E+03 2.42E+03 3.20E+01 
2 3.67E+02 2.28E+03 1.91E+01 
3 1.69E+02 2.10E+03 2.51E+01 
4 1.10E+02 1.93E+03 3.05E+01 
5 9.48E+01 1.77E+03 3.45E+01 
6 9.24E+01 1.63E+03 3.73E+01 
7 9.31E+01 1.49E+03 3.90E+01 
8 9.37E+01 1.37E+03 3.99E+01 
9 9.35E+01 1.25E+03 4.01E+01 
10 9.23E+01 1.15E+03 3.98E+01 






















Table 6.5.22 Count rate per CDL calculated for the Adipose Male phantom contaminated with I-131 
Back Right Lung Neck Thigh 
 cpm per CDL cpm per CDL cpm per CDL 
0 6.18E+03 5.98E+01 3.62E+00 
1 7.37E+02 2.54E+03 3.05E+01 
2 2.51E+02 2.41E+03 1.83E+01 
3 1.14E+02 2.21E+03 2.43E+01 
4 7.37E+01 2.03E+03 2.96E+01 
5 6.29E+01 1.86E+03 3.36E+01 
6 6.10E+01 1.71E+03 3.63E+01 
7 6.14E+01 1.56E+03 3.80E+01 
8 6.18E+01 1.43E+03 3.88E+01 
9 6.16E+01 1.31E+03 3.91E+01 
10 6.08E+01 1.20E+03 3.88E+01 




























Table 6.5.23 Count rate per CDL calculated for the Adipose Female phantom contaminated with I-131 
Back Right Lung Neck Thigh   
  cpm per CDL cpm per CDL cpm per CDL 
0 6.73E+03 6.26E+01 5.93E+00 
1 8.09E+02 2.04E+03 4.62E+01 
2 2.77E+02 1.93E+03 2.85E+01 
3 1.28E+02 1.78E+03 3.79E+01 
4 8.36E+01 1.63E+03 4.63E+01 
5 7.20E+01 1.50E+03 5.24E+01 
6 7.00E+01 1.38E+03 5.66E+01 
7 7.04E+01 1.26E+03 5.92E+01 
8 7.08E+01 1.16E+03 6.06E+01 
9 7.05E+01 1.06E+03 6.09E+01 
10 6.96E+01 9.73E+02 6.05E+01 






















Table 6.5.24 Count rate per CDL calculated for the Post-Menopausal Adipose Female phantom contaminated 
with I-131 
Back Right Lung Neck Thigh   
  cpm per CDL cpm per CDL cpm per CDL 
0 6.54E+03 6.80E+01 5.52E+00 
1 7.84E+02 2.31E+03 2.33E+01 
2 2.68E+02 2.18E+03 1.37E+01 
3 1.23E+02 2.01E+03 1.79E+01 
4 7.92E+01 1.84E+03 2.17E+01 
5 6.74E+01 1.69E+03 2.45E+01 
6 6.51E+01 1.56E+03 2.64E+01 
7 6.52E+01 1.43E+03 2.76E+01 
8 6.54E+01 1.31E+03 2.83E+01 
9 6.50E+01 1.20E+03 2.84E+01 
10 6.41E+01 1.10E+03 2.82E+01 



























Table 6.5.25 Count rate per CDL calculated for the Child phantom contaminated with I-131 
Back Right Lung Neck Thigh   
  cpm per CDL cpm per CDL cpm per CDL 
0 4.80E+03 2.92E+01 1.06E+01 
1 5.89E+02 7.15E+02 1.58E+01 
2 2.02E+02 6.66E+02 9.42E+00 
3 9.57E+01 6.20E+02 1.18E+01 
4 6.42E+01 5.76E+02 1.40E+01 
5 5.58E+01 5.34E+02 1.57E+01 
6 5.44E+01 4.95E+02 1.69E+01 
7 5.45E+01 4.59E+02 1.76E+01 
8 5.46E+01 4.24E+02 1.79E+01 
9 5.43E+01 3.92E+02 1.80E+01 
10 5.34E+01 3.62E+02 1.78E+01 






















Table 6.5.26 Count rate per CDL calculated for the Male phantom contaminated with I-192 
Back Right Lung Front Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL cpm per CDL 
0 1.66E+04 1.59E+04 1.47E+02 8.29E+00 
1 6.50E+03 6.26E+03 8.46E+02 4.62E+02 
2 5.20E+03 5.02E+03 8.73E+02 4.54E+02 
3 4.67E+03 4.51E+03 8.65E+02 4.27E+02 
4 4.42E+03 4.27E+03 8.58E+02 4.12E+02 
5 4.27E+03 4.13E+03 8.53E+02 4.06E+02 
6 4.17E+03 4.03E+03 8.49E+02 4.02E+02 
7 4.08E+03 3.94E+03 8.45E+02 4.00E+02 
8 4.00E+03 3.86E+03 8.42E+02 3.98E+02 
9 3.92E+03 3.79E+03 8.38E+02 3.97E+02 
10 3.84E+03 3.72E+03 8.35E+02 3.95E+02 




























Table 6.5.27 Count rate per CDL calculated for the Female phantom contaminated with I-192 
Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 1.55E+04 1.51E+02 1.05E+01 
1 6.24E+03 8.84E+02 4.30E+02 
2 5.04E+03 9.12E+02 4.20E+02 
3 4.55E+03 9.04E+02 3.92E+02 
4 4.32E+03 8.97E+02 3.78E+02 
5 4.18E+03 8.92E+02 3.71E+02 
6 4.08E+03 8.87E+02 3.68E+02 
7 4.00E+03 8.83E+02 3.66E+02 
8 3.92E+03 8.80E+02 3.64E+02 
9 3.85E+03 8.76E+02 3.63E+02 
10 3.78E+03 8.73E+02 3.62E+02 






















Table 6.5.28 Count rate per CDL calculated for the Adipose Male phantom contaminated with I-192 
Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 1.07E+04 1.16E+02 3.50E+00 
1 4.31E+03 7.67E+02 4.12E+02 
2 3.48E+03 7.95E+02 4.06E+02 
3 3.14E+03 7.89E+02 3.82E+02 
4 2.98E+03 7.84E+02 3.69E+02 
5 2.88E+03 7.79E+02 3.63E+02 
6 2.82E+03 7.75E+02 3.60E+02 
7 2.76E+03 7.72E+02 3.58E+02 
8 2.70E+03 7.69E+02 3.56E+02 
9 2.65E+03 7.66E+02 3.55E+02 
10 2.60E+03 7.64E+02 3.54E+02 




























Table 6.5.29 Count rate per CDL calculated for the Adipose Female phantom contaminated with I-192 
502 - Back Right 
Lung 542 - Neck 562 - Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 1.18E+04 1.14E+02 8.11E+00 
1 4.76E+03 7.50E+02 5.98E+02 
2 3.85E+03 7.76E+02 6.08E+02 
3 3.48E+03 7.70E+02 5.90E+02 
4 3.30E+03 7.64E+02 5.79E+02 
5 3.20E+03 7.60E+02 5.73E+02 
6 3.12E+03 7.56E+02 5.70E+02 
7 3.06E+03 7.53E+02 5.67E+02 
8 3.00E+03 7.50E+02 5.65E+02 
9 2.94E+03 7.47E+02 5.63E+02 
10 2.89E+03 7.44E+02 5.61E+02 






















Table 6.5.30 Count rate per CDL calculated for the Post-Menopausal Adipose Female phantom contaminated 
with I-192 
Back Right Lung Neck Thigh 
  cpm per CDL cpm per CDL cpm per CDL 
0 1.15E+04 1.28E+02 3.69E+00 
1 4.63E+03 8.43E+02 3.23E+02 
2 3.73E+03 8.74E+02 3.09E+02 
3 3.37E+03 8.67E+02 2.84E+02 
4 3.19E+03 8.61E+02 2.71E+02 
5 3.09E+03 8.56E+02 2.65E+02 
6 3.02E+03 8.52E+02 2.62E+02 
7 2.95E+03 8.48E+02 2.60E+02 
8 2.90E+03 8.45E+02 2.59E+02 
9 2.84E+03 8.42E+02 2.58E+02 
10 2.79E+03 8.39E+02 2.57E+02 


























Table 6.5.31 Count rate per CDL calculated for the Child phantom contaminated with I-192 
Back Right Lung Neck Thigh   
  cpm per CDL cpm per CDL cpm per CDL 
0 1.45E+04 1.42E+02 1.89E+01 
1 5.91E+03 1.03E+03 3.58E+02 
2 4.78E+03 1.06E+03 3.42E+02 
3 4.32E+03 1.05E+03 3.14E+02 
4 4.10E+03 1.04E+03 3.00E+02 
5 3.98E+03 1.04E+03 2.94E+02 
6 3.88E+03 1.03E+03 2.90E+02 
7 3.80E+03 1.03E+03 2.89E+02 
8 3.73E+03 1.02E+03 2.87E+02 
9 3.66E+03 1.02E+03 2.86E+02 
10 3.59E+03 1.02E+03 2.85E+02 





























The Captus 3000 Thyroid Uptake System can be used to assess the internal 
contamination in an individual following the use of a RDD for some isotopes.  These isotopes 
include Co-60, Cs-137, Ir-192, and I-131.  The thyroid uptake system cannot be used to detect 
internal contamination due to Am-241.  The calculated count rate per one CDL of Am-241 is too 
low to differentiate it from background using this system.  This is a consequence of the low dose 
coefficient and the low energy of the gamma-ray emission of Am-241.  Even at a relatively high 
intake of Am-241 (1 CDL) the count rate from the thyroid uptake collimator is less than one 
count per minute. 
In an emergency scenario, it would be more beneficial to identify the isotope than to 
spend time determining the BMI or body type of the individuals being scanned.  The optimal 
position for the thyroid uptake collimator depends on the isotope inhaled.  If the isotope has not 
been identified, the most optimal position is the back right lung followed by the neck.  The thigh 
should not be chosen as a detection position for the thyroid uptake collimator unless 
circumstances prevent use of the other two locations.  This is one of the consequences of a high 
degree of collimation.  The detection efficiency is reduced as a result of a smaller angle seen by 
the detector, and the distance between the detector and the object of interest.  
Given the threshold of one CDL, the minimum necessary counting time is one minute.  
This can be used as a baseline for all isotopes on the back right lung, with the exception of I-131, 
in which the probe would need to be placed on the neck for this counting time.  In a situation 
 
72 
where large numbers of people are potentially contaminated, it is important to use the minimum 









Based on the conclusions from this investigation, other methods for detecting Am-241 
need to be developed.  Possible methods include urinalysis or fecal studies to detect low levels of 
this isotope.  It is likely that these methodologies must retain high efficiency even a high levels 
of background, otherwise they will not be applicable for this application. 
Another feature of the Captus 3000 Thyroid Uptake System is the Bioassay collimator, 
which was not fully considered in this analysis.  With a considerably shorter collimator, it is 
possible that the bioassay collimator could be used to detect isotopes with a smaller dose 
coefficient (such as Am-241) following an RDD event. It would also tend to have lower decision 
levels, allowing it to detect smaller activities in a human.   
This work focused on inhalation as the method of intake for each radionuclide.  By 
considering ingestion, the work can be expanded to cover the two main routes of intake.  This 
would require repeating the biokinetic analysis for ingestion and positioning the thyroid uptake 
collimator over the abdomen rather than the lungs or neck. 
Finally, the validated model of the thyroid uptake probe could be used in conjunction 
with newly developed voxel phantoms.  Voxel phantoms are based on digital images captured 
from studies completed on actual humans using Computed Tomography (CT) or Magnetic 
Resonance Imaging (MRI).  While many of these phantoms are still undergoing development 
and validation, it is possible that they could provide a more realistic representation of various 




THYROID UPTAKE COLLIMATOR AND SLAB PHANTOM MCNP INPUT FILE 
 
75 
Thyroid Uptake Collimator - 30mmPMMA, Cs-137 
c Cell Cards             
1     1   -0.0012    1 2 3 17 19 20 -99             imp:p=1 $ Outside Air   
2     2   -3.67     -5                                          imp:p=1 $ NaI crystal              
3     4   -1.19     -1:-2 3 4                               imp:p=1 $ PMMA               
4     3   -7.82      (-17 10):(-19 18): -20         imp:p=1 $ Steel                
5     5   -1.03     -3 2                                      imp:p=1 $ Virtual Water          
6     6   -2.7       5 14 -6                                 imp:p=1 $ Aluminum                 
7     7   -1        -4                                           imp:p=1 $ Source    
8     0             -9 5                                         imp:p=1 $ Vacuum  
9     1   -0.0012   -7                                       imp:p=1 $ Air in coll 
10    3   -7.82      (7 -11)                               imp:p=1 $ Inner Steel Liner 
11    8   -11.4     (-10 11):(-18 11 12 16 21)  imp:p=1 $ Pb innards 
12    1  -.0012     -18 16 -21                           imp:p=1 $ air in back 
13    9   -8.4      (-14 15):(-12 13)                  imp:p=1 $ Brass Ring 
14    1   -0.0012    6 11 -15                           imp:p=1 $ Air ret ring  
15    1   -0.0012   -13 6 9 14 15                    imp:p=1 $ Air in brass tube 
16    10  -11.4     -16 12                                imp:p=1 $ Pure Led sheet 
99    0              99                                          imp:p=0 $ Universe 
 
c Surface Cards          
1       rpp  0 3.0 -30 30 -30 30                    $ PMMA slab            
2       rpp  3.0 3.6 -30 30 -30 30                  $ Source Holder             
3       rpp  3.6001 13.6 -30 30 -30 30              $ Virtual Water       
4       rcc  3.3001 -1.15 0 0 2.3 0 .2              $ Source     
5       rcc -21.5051 0 0 5.08 0 0 2.54              $ NaI Crystal          
6       rcc -21.5051 0 0 5.1308 0 0 2.824           $ Al Housing 
9       rcc -34.7893 0 0 13.2842 0 0 2.921          $ PMT Tubes space 
10      trc -11.5824 0 0 11.5824 0 0 4.445 5.3975   $ Outer Detector Housing ID 
17      trc -11.5824 0 0 11.5824 0 0 4.7625 5.715   $ Outer Detector Housing OD 
11      trc -15.7393 0 0 15.7393 0 0 2.7344 4.8018  $ Inner Steel Liner        
7       trc -15.7393 0 0 15.7393 0 0 2.5344 4.6018  $ Air in collimator          
12      rcc -40.8223 0 0 25.083 0 0 3.505           $ Inner Tube OD around PMT 
13      rcc -40.8223 0 0 25.083 0 0 3.175           $ Inner Tube ID   
14      rcc -16.3743 0 0 0.635 0 0 3.175            $ Retaining Ring OD 
15      rcc -16.3743 0 0 0.635 0 0 2.565            $ Retaining Ring ID (air) 
16      rcc -40.8223 0 0 14.9225 0 0 3.823          $ Detector Side Shield (Pb) 
18      rcc -40.8223 0 0 29.2399 0 0 4.445          $ Cyl Detector Housing ID 
19      rcc -40.8223 0 0 29.2399 0 0 4.7625         $ Cyl Detector Housing OD 
20      rcc -41.8223 0 0 1.0 0 0 4.7625             $ Back end cap 
21      px -25.8998                                 $ air plane! 
99      rpp -50 50 -50 50 -50 50                    $ Universe  
 
c Data Cards             
c Material Card for Air (NIST DRY AIR)                
m1    8016.             -0.232   
      7014.             -0.755 
      6012              -1.20E-4 
      18000.42c         -1.28E-2  
c Material Card for Sodium Iodide   
m2    11000.04p           0.5   
      53000.04p           0.5  
c Material Card for grain controlled mild steel  
m3    26054            -0.05821 
      26056            -0.9137 
      26057            -0.0211      26058            -0.00281 
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       6012            -0.0006 
      25055            -0.0035 
      15031            -0.00004 
      16000            -0.00005 
c Material Card for PMMA               
m4    6000.            0.3333   
      8016.            0.1333  
      1001.            0.5333  
c Material Card for Virtual Water      
m5    1001.            0.0802   
      6000.            0.6703  
      7015.            0.0214  
      8016.            0.1991  
      17000.           0.0014  
      20000.           0.0231  
c Material Card for Aluminum           
m6    13027.  1   
c Material Card for polyester (sources)              
m7    6000.             0.333   
      1001.             0.533  
      8016.             0.133  
c Material Card for Antimonial Lead 
m8    82000   0.96 
      51000   0.04 
c Material Card for High Brass 
m9    29000    0.65 
      30000    0.35 
c Material Card for Pure Lead 
m10    82000   1 
mode  p 
phys:p 4j 1              
sdef par=2 rad=d1 ext=d2 pos=3.3 0 0 axs=0 1 0 vec=0 0 1 erg=d3      
si1 0 0.2                  
sp1 -21 1                
si2 -1.15 1.15           
sp2 -21 0                
si3 l 0.661645   
sp3   .897759 
c Two Tallys             
f8:p 2  $ volume of crystal            
f18:p 2  $ same volume                 
c energy bins            
e0 0 1e-8 0.005 1024i 2.046                  
c Gaussian Energy Broadening           
ft8 GEB -0.00298579 0.0925102 -0.4     




































































































































































































































































































































































































































































































































Figure B.13 Measured and calculated spectra for Mn-54 with 0 mm PMMA 
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CONDENSED MIRD PHANTOM MCNP INPUT FILE 
 
88 
Male Phantom contaminated with Cs-137 
1     1 -.001293    -1 (607:-37:606) (-606:601:35) (600:-35) & 
                    (-615:37:-43:44:4:-616) (37:-608:609) & 
                    (37:-608:610) 900 901 902 903 
2     2 -0.2958     ((-2 -4 3):(-2 4)) 5                                  $ left lung 
3     3 -0.9869     -7 51 -6 (-8:32) 84 101 #2 #24 #28 #58 #59 
                    (113:115) (114:115) #62 #700                          $ torso insd ribs/lvrtop-shldr 
4     3 -0.9869     -7 8 -32 117 113 114 #15 #16 #17 #18 #19 #20 #700 
                    (-4:-9:116:118:-119) (-4:-9:116:120:-121)             $torso 
5     3 -0.9869     -7 8 -117 51 113 114 #9 #13 #14 #700                  $ torso 
6     3 -0.9869     -7 50 -51 56 84 96 105 106 113 114 #10 #11 #12 
                    #27 #32 #43 #44 #47 #700                              $ torso 
7     3 -0.9869     -7 97 -50 (83:-86:87:-88) 113 114 #30 #33 #38 #39 
                    #63 #64 #65 #700                                      $ torso abdoman 
8     3 -0.9869     -7 37 -97 95 113 114 #31 #33 #38 #65 #66 #700         $ torso abdoman 
9     4 -1.4862     8 -9 5 -10                                            $ rib 
10    4 -1.4862     8 -9 11 -12                                           $ rib 
11    4 -1.4862     8 -9 13 -14                                           $ rib 
12    4 -1.4862     8 -9 15 -16                                           $ rib 
13    4 -1.4862     8 -9 17 -18                                           $ rib 
14    4 -1.4862     8 -9 19 -20                                           $ rib 
15    4 -1.4862     8 -9 21 -22                                           $ rib 
16    4 -1.4862     8 -9 23 -24                                           $ rib 
17    4 -1.4862     8 -9 25 -26                                           $ rib 
18    4 -1.4862     8 -9 27 -28                                           $ rib 
19    4 -1.4862     8 -9 29 -30                                           $ rib 
20    4 -1.4862     8 -9 31 -32                                           $ rib 
21    3 -0.9869     ((35 -34):(-33 6 -35)) 102 (84:85) 
                    #37 #60 #61 #62 #700                                  $ head 
22    3 -0.9869     -37 38 -39 103 #700                                   $ left leg 
23    3 -0.9869     -37 38 -40 104 #22 #700                               $ right leg 
24    2 -0.2958     ((-41 -4 42):(-41 4)) 5                               $ right lung 
25    3 -0.9869     715 -37 43 -44 -4 716 39 40 72 73 #700 #600           $ genitalia 
26    3 -0.9869     -47                                                   $ brain 
27    3 -0.9869     50 -51 -48 -49 #10 #11 #12                            $ liver 
28    3 -0.9869     (-52 54):(-53 -54 55)                                 $ heart 
29    3 -0.9869     -56                                                   $ stomach 
30    3 -0.9869     138 -57 58 -59                                        $ Ascending Colon Wall  
31    3 -0.9869     (-63 141 65 -61):(-64 142 37 -65)                     $ Sigmoid Colon Wall 
32    3 -0.9869     -62 139 66 -67 59                                     $ Transverse Colon Wall 
33    3 -0.9869     -60 140 61 -59 -83                                    $ Descending Colon Wall 
35    3 -0.9869     -72                                                   $ testicle 
36    3 -0.9869     -73                                                   $ testicle 
37    3 -0.9869     -74 75 -76 6 -77                                      $ thyroid 
38    4 -1.4862     -82 83 37 -78 80 (79:-81)                             $ pelvis 
39    4 -1.4862     -84 78 -85 102                                        $ spine 
40    3 -0.9869     -83 86 -50 88 -87 #30 #32 #33 #63 #64 #65             $ small int. 
41    1 -0.001293   -107 606 -4                                           $ air 
42    1 -0.001293   -108 606 -4                                           $ air 
43    3 -0.9869     -92 65                                                $ kidney 
44    3 -0.9869     -93 -94                                               $ kidney 
45    3 -0.9869     -95                                                   $ bladder 
46    3 -0.9869     -96                                                   $ spleen 
47    3 -0.9869     -98 99 (-65:100)                                      $ pancreas 
48    3 -0.9869     -101                                                  $ thymus 
49    4 -1.4862     47 -102 #60 #61                                       $ skull 
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50    4 -1.4862     -103 38 -37                                           $ leg bone 
51    4 -1.4862     -104 38 -37                                           $ leg bone 
52    3 -0.9869     -105 92                                               $ adrenal 
53    3 -0.9869     -106 93                                               $ adrenal 
54    4 -1.4862     37 -115 -113                                          $ arm bone 
55    4 -1.4862     37 -115 -114                                          $ arm bone 
56    4 -1.4862     4 9 -32 -116 117 -118 119                             $ scapulae 
57    4 -1.4862     4 9 -32 -116 117 -120 121                             $ scapulae 
58    4 -1.4862     -4 -122 -123 124                                      $ clavicle 
59    4 -1.4862     -4 -122 -125 126                                      $ clavicle 
60    3 -0.9869     -33 128 129 -130 133 -134 -4 #700                     $ eye lense 
61    3 -0.9869     -33 128 -131 132 133 -134 -4 #700                     $ eye lense 
62    3 -0.9869     -77 -137 51                                           $ oesophagus 
63    3 -0.9869     -138 58 -59                                           $ Ascending Colon Interior  
64    3 -0.9869     -139 66 -67                                           $ Transvers Colon Interior 
65    3 -0.9869     -140 61 -59 -83                                       $ Decending Colon Interior 
66    3 -0.9869     (-141 65 -61) : (-142 37 -65)                         $ Sigmoid Colon Interior 
600   0             -600 35 34 902 : -601 33 -35 606 902 : &                $ Head & Neck 
                    -606 6 33 -607 902: -607 7 -6 37 900 901 902 : &   $ Shoulders & Torso 
  (((-46 616) (43 -44) (615 -37)):((615 -45)(610 609)(46 -4)(43 -44))): & $ Genitalia 
                    -610 40 -37 38 : -609 39 -37 38 903: &                $ Legs 
                    -708 608 -609 : -708 608 -610 : &                     $ Feet 
                    -38 708 -610 40 : -38 708 -609 39                      
700   5 -1.04       700 35 102 -34 : 701 -33 -35 6 : &                    $ Head & Neck 
                    706 -6 701 -707 : 707 -7 -6 37 114 113 : &            $ Shoulders & Torso 
  (((46 -716)(43 -44)(609 610)(715 -37)):((-715 45)(610 609)(46 -4)(43 -44))): & $ Genitalia 
                    -40 710 -37 38 : -39 709 -37 38 : &                   $ Legs 
                    -38 708 -39 : -38 708 -40                             $ Feet 
900   1 -.001293    -900 7 515 514 505 504 
901   1 -.001293    -901 7 535 534 525 524 
902   1 -.001293    -902 6 33 34 555 554 545 544 
903   1 -.001293    -903 39 575 574 565 564 
c Detector in box 900  
502   502   -3.67     -501                               $ NaI crystal                   
503   503   -7.82      (-505 504):(-514 513): -515       $ Steel                      
504   506   -2.7       501 510 -502                      $ Aluminum                    
505   501   -0.00012  -503                               $ Vacuum  
506   501   -0.0012   -507                               $ Air in coll 
507   503   -7.82     (507 -506)                         $ Inner St Liner 
508   508   -11.4     (-504 506):(-513 506 508 512 516)  $ Pb innards 
509   501  -.0012    -513 512 -516                       $ air in back 
510   509   -8.4      (-510 511):(-508 509)              $ Brass Ring 
511   501   -0.0012   502 506 -511                       $ Air ret ring  
512   501   -0.0012  -509 502 503 510 511                $ Air in brs tube 
513   510  -11.4     -512 508                            $ Pure Led sheet                    
c Detector in box 901   
522   502   -3.67     -521                               $ NaI crystal                   
523   503   -7.82      (-525 524):(-534 533): -535       $ Steel                      
524   506   -2.7       521 530 -522                      $ Aluminum                    
525   501   -0.00012  -523                               $ Vacuum  
526   501   -0.0012   -527                               $ Air in coll 
527   503   -7.82     (527 -526)                         $ Inner St Liner 
528   508   -11.4     (-524 526):(-533 526 528 532 536)  $ Pb innards 
529   501  -.0012    -533 532 -536                       $ air in back 
530   509   -8.4      (-530 531):(-528 529)              $ Brass Ring 
531   501   -0.0012   522 526 -531                       $ Air ret ring  
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532   501   -0.0012  -529 522 523 530 531                $ Air in brs tube 
533   510  -11.4     -532 528                            $ Pure Led sheet                        
c Detector in box 902  
542   502   -3.67     -541                               $ NaI crystal                   
543   503   -7.82      (-545 544):(-554 553): -555       $ Steel                      
544   506   -2.7       541 550 -542                      $ Aluminum                    
545   501   -0.00012  -543                               $ Vacuum  
546   501   -0.0012   -547                               $ Air in coll 
547   503   -7.82     (547 -546)                         $ Inner St Liner 
548   508   -11.4     (-544 546):(-553 546 548 552 556)  $ Pb innards 
549   501  -.0012    -553 552 -556                       $ air in back 
550   509   -8.4      (-550 551):(-548 549)              $ Brass Ring 
551   501   -0.0012   542 546 -551                       $ Air ret ring  
552   501   -0.0012  -549 542 543 550 551                $ Air in brs tube 
553   510  -11.4     -552 548                            $ Pure Led sheet                       
c Detector in box 903 
562   502   -3.67     -561                               $ NaI crystal                   
563   503   -7.82      (-565 564):(-574 573): -575       $ Steel                      
564   506   -2.7       561 570 -562                      $ Aluminum                    
565   501   -0.00012  -563                               $ Vacuum  
566   501   -0.0012   -567                               $ Air in coll 
567   503   -7.82     (567 -566)                         $ Inner St Liner 
568   508   -11.4     (-564 566):(-573 566 568 572 576)  $ Pb innards 
569   501  -.0012    -573 572 -576                       $ air in back 
570   509   -8.4      (-570 571):(-568 569)              $ Brass Ring 
571   501   -0.0012   562 566 -571                       $ Air ret ring  
572   501   -0.0012  -569 562 563 570 571                $ Air in brs tube 
573   510  -11.4     -572 568                            $ Pure Led sheet                          






C      2 concentric elliptical cylinders and planes to define eye lenses 
127   SQ  100 64 0 0 0 0 -6400 0 0 0 
128   SQ  88.36 40.96 0 0 0 0 -3619.2256 0 0 0 
129   PX  2 
130   PX  4 
131   PX  -2 
132   PX  -4 
133   PZ  82.5 
134   PZ  84.5 
C      segmenting planes for RBM regions in leg and arm bones 
135   PZ  -22.8 
136   PZ  52.6 
C      Oesophagus 
137   SQ 0.16 1.0 0 0 0 0 -0.16 0.5 2.5 0                            $ Oesophagus Exterior 
C      Colon Wall 
138   SQ 1 1 0 0 0 0 -3.209 -8.5 -2.36 0                             $ Ascending Colon Interior 
139   SQ 0 0.9467 3.8927 0 0 0 -3.6854 0 -2.36 25.5 
140   GQ 1.796 2.496 0.0674 0 0.818 -0.066 -30.75 -7.12 -0.602 132.2 
141   TY 3 0 8.72 5.72 0.91 0.91                                     $ Upper Sigmoid Interior 
142   TY 3 0 0 3 0.91 0.91                                           $ Lower Sigmoid Interior 
C Boxes for Detectors 
900 900 BOX 0.39 10.9607 38.36   -17.78 0 0 & 
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        0 50.8 0      0 0 17.78 
901 901 BOX 0.39 -10.9609 38.35  -17.78 0 0 & 
        0 -50.8 0     0 0 17.80 
902 BOX -8.89 -10 70.01  17.78 0 0  0 -50.8 0   0 0 17.78 
903 903 BOX 19.98 -8.89 0  50.8 0 0  0 17.78 0  0 0 -17.78 
c 
c c 
c Detector in Box 900 
501 501   rcc -21.5051 0 0 5.08 0 0 2.54              $ NaI Crystal          
502 501   rcc -21.5051 0 0 5.1308 0 0 2.824           $ Al Housing 
503 501   rcc -34.7893 0 0 13.2842 0 0 2.921          $ PMT Tubes space 
504 501   trc -11.5824 0 0 11.5824 0 0 4.445 5.3975   $ Outer Detector Housing ID 
505 501   trc -11.5824 0 0 11.5824 0 0 4.7625 5.715   $ Outer Detector Housing OD 
506 501   trc -15.7393 0 0 15.7393 0 0 2.7344 4.8018  $ Inner Steel Liner        
507 501   trc -15.7393 0 0 15.7393 0 0 2.5344 4.6018  $ Air in collimator          
508 501   rcc -40.8223 0 0 25.083 0 0 3.505           $ Inner Tube OD around PMT 
509 501   rcc -40.8223 0 0 25.083 0 0 3.175           $ Inner Tube ID   
510 501   rcc -16.3743 0 0 0.635 0 0 3.175            $ Retaining Ring OD 
511 501   rcc -16.3743 0 0 0.635 0 0 2.565            $ Retaining Ring ID (air) 
512 501   rcc -40.8223 0 0 14.9225 0 0 3.823          $ Detector Side Shield (Pb) 
513 501   rcc -40.8223 0 0 29.2399 0 0 4.445          $ Cyl Detector Housing ID 
514 501   rcc -40.8223 0 0 29.2399 0 0 4.7625         $ Cyl Detector Housing OD 
515 501   rcc -41.8223 0 0 1.0 0 0 4.7625             $ Back end cap 
516 501   px -25.8998                                 $ air plane! 
c Detector in Box 901 
521 502   rcc -21.5051 0 0 5.08 0 0 2.54              $ NaI Crystal          
522 502   rcc -21.5051 0 0 5.1308 0 0 2.824           $ Al Housing 
523 502   rcc -34.7893 0 0 13.2842 0 0 2.921          $ PMT Tubes space 
524 502   trc -11.5824 0 0 11.5824 0 0 4.445 5.3975   $ Outer Detector Housing ID 
525 502   trc -11.5824 0 0 11.5824 0 0 4.7625 5.715   $ Outer Detector Housing OD 
526 502   trc -15.7393 0 0 15.7393 0 0 2.7344 4.8018  $ Inner Steel Liner        
527 502   trc -15.7393 0 0 15.7393 0 0 2.5344 4.6018  $ Air in collimator          
528 502   rcc -40.8223 0 0 25.083 0 0 3.505           $ Inner Tube OD around PMT 
529 502   rcc -40.8223 0 0 25.083 0 0 3.175           $ Inner Tube ID   
530 502   rcc -16.3743 0 0 0.635 0 0 3.175            $ Retaining Ring OD 
531 502   rcc -16.3743 0 0 0.635 0 0 2.565            $ Retaining Ring ID (air) 
532 502   rcc -40.8223 0 0 14.9225 0 0 3.823          $ Detector Side Shield (Pb) 
533 502   rcc -40.8223 0 0 29.2399 0 0 4.445          $ Cyl Detector Housing ID 
534 502   rcc -40.8223 0 0 29.2399 0 0 4.7625         $ Cyl Detector Housing OD 
535 502   rcc -41.8223 0 0 1.0 0 0 4.7625             $ Back end cap 
536 502   px -25.8998                                 $ air plane! 
c Detector in Box 902 
541 503   rcc -21.5051 0 0 5.08 0 0 2.54              $ NaI Crystal          
542 503   rcc -21.5051 0 0 5.1308 0 0 2.824           $ Al Housing 
543 503   rcc -34.7893 0 0 13.2842 0 0 2.921          $ PMT Tubes space 
544 503   trc -11.5824 0 0 11.5824 0 0 4.445 5.3975   $ Outer Detector Housing ID 
545 503   trc -11.5824 0 0 11.5824 0 0 4.7625 5.715   $ Outer Detector Housing OD 
546 503   trc -15.7393 0 0 15.7393 0 0 2.7344 4.8018  $ Inner Steel Liner        
547 503   trc -15.7393 0 0 15.7393 0 0 2.5344 4.6018  $ Air in collimator          
548 503   rcc -40.8223 0 0 25.083 0 0 3.505           $ Inner Tube OD around PMT 
549 503   rcc -40.8223 0 0 25.083 0 0 3.175           $ Inner Tube ID   
550 503   rcc -16.3743 0 0 0.635 0 0 3.175            $ Retaining Ring OD 
551 503   rcc -16.3743 0 0 0.635 0 0 2.565            $ Retaining Ring ID (air) 
552 503   rcc -40.8223 0 0 14.9225 0 0 3.823          $ Detector Side Shield (Pb) 
553 503   rcc -40.8223 0 0 29.2399 0 0 4.445          $ Cyl Detector Housing ID 
554 503   rcc -40.8223 0 0 29.2399 0 0 4.7625         $ Cyl Detector Housing OD 
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555 503   rcc -41.8223 0 0 1.0 0 0 4.7625             $ Back end cap 
556 503   px -25.8998                                 $ air plane! 
c Detector in Box 903 
561 504   rcc -21.5051 0 0 5.08 0 0 2.54              $ NaI Crystal          
562 504   rcc -21.5051 0 0 5.1308 0 0 2.824           $ Al Housing 
563 504   rcc -34.7893 0 0 13.2842 0 0 2.921          $ PMT Tubes space 
564 504   trc -11.5824 0 0 11.5824 0 0 4.445 5.3975   $ Outer Detector Housing ID 
565 504   trc -11.5824 0 0 11.5824 0 0 4.7625 5.715   $ Outer Detector Housing OD 
566 504   trc -15.7393 0 0 15.7393 0 0 2.7344 4.8018  $ Inner Steel Liner        
567 504   trc -15.7393 0 0 15.7393 0 0 2.5344 4.6018  $ Air in collimator          
568 504   rcc -40.8223 0 0 25.083 0 0 3.505           $ Inner Tube OD around PMT 
569 504   rcc -40.8223 0 0 25.083 0 0 3.175           $ Inner Tube ID   
570 504   rcc -16.3743 0 0 0.635 0 0 3.175            $ Retaining Ring OD 
571 504   rcc -16.3743 0 0 0.635 0 0 2.565            $ Retaining Ring ID (air) 
572 504   rcc -40.8223 0 0 14.9225 0 0 3.823          $ Detector Side Shield (Pb) 
573 504   rcc -40.8223 0 0 29.2399 0 0 4.445          $ Cyl Detector Housing ID 
574 504   rcc -40.8223 0 0 29.2399 0 0 4.7625         $ Cyl Detector Housing OD 
575 504   rcc -41.8223 0 0 1.0 0 0 4.7625             $ Back end cap 
576 504   px  -25.8998                                $ air plane! 
 





IMP:P 1 118R 0 
C 
C Sources 
SDEF  PAR=2  ERG=D1  CEL=D2  RAD=fcel=D3  & 
      POS=fcel=D4  EXT=fcel=D5  AXS=fcel=D6  
SI1 L 0.662 0.0332 0.0318 
SP1 0.898 0.0392 0.0213 
C Left Lung, Right Lung, Stomach, Small Int., Heart, Ascending Colon,  
C Sigmoid Colon, Transvers Colon, Descending Colon, Bladder,  
C Body Tissue (3, 4, 5, 6, 7, 8, 21, 22, 23, 25) 
SI2 L 2 24 29 40 28 30 31 32 33 45 3 4 5 6 7 8 21 22 23 25 
SP2 D 1 1  1  1  1  1  1  1  1  1  1 1 1 1 1 1 1  1  1  1  
DS3 S 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 
DS4 L 8.5 0 43.4   -8.5 0 43.4   8 -4 35   0 -3.8 11.3   -1 -3 51   & 
      -8.5 -2.36 14.35   5 0 -0.1   -10.6 -2.36 25.5   8.72 0 8.52  & 
      0 -4.5 8   0 0 42.9   0 0 50.8   0 0 42.9   0 0 26.9          & 
      0 0 11.9   0 0 -0.1   0 0 69.9   10.5 0 -80.1   -10.5 0 -80.1 & 
      0 -8 -4.9 
DS5 S 30 31 0 32 0 33 34 35 36 0 37 38 39 40 41 42 43 44 45 46 
DS6 L 0 0 1   0 0 1   0 0 0   0 0 1   0 0 0   0 0 1   0 0 1 & 
      1 0 0   0 0 1   0 0 0   0 0 1   0 0 1   0 0 1   0 0 1 & 
      0 0 1   0 0 1   0 0 1   0 0 1   0 0 1   0 0 1 
SI7  0 7.6 
SP7  -21 1 
SI8  0 7.6 
SP8  -21 1 
SI9  0 8.2 
SP9  -21 2 
SI10 0 11.4 
SP10 -21 1 
SI11 0 8.2 
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SP11 -21 2 
SI12 0 2.6 
SP12 -21 1 
SI13 0 7.1 
SP13 -21 1 
SI14 0 3.85 
SP14 -21 1  
SI15 0 4 
SP15 -21 1  
SI16 0 5.2 
SP16 -21 2 
SI17 0 20.2 
SP17 -21 1 
SI18 0 20.3 
SP18 -21 1 
SI19 0 20.3 
SP19 -21 1 
SI20 0 20.3 
SP20 -21 1 
SI21 0 20.3 
SP21 -21 1 
SI22 0 20.3 
SP22 -21 1 
SI23 0 10.1 
SP23 -21 1 
SI24 0 11 
SP24 -21 1 
SI25 0 11 
SP25 -21 1 
SI26 0 8.1 
SP26 -21 1 
SI27 0 16.6 
SP27 -21 1 
SI30 0 24.6 
SP30 -21 0 
SI31 0 24.6 
SP31 -21 0 
SI32 0 10.2  
SP32 -21 0 
SI33 0 9.75 
SP33 -21 0 
SI34 0 8.92 
SP34 -21 0 
SI35 0 21.2 
SP35 -21 0 
SI36 0 16 
SP36 -21 0 
SI37 0 27.2 
SP37 -21 0 
SI38 0 16.6 
SP38 -21 0 
SI39 0 8.1 
SP39 -21 0 
SI40 0 16.2 
SP40 -21 0 
SI41 0 15.2 
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SP41 -21 0 
SI42 0 12.2 
SP42 -21 0 
SI43 0 24.2 
SP43 -21 0 
SI44 0 80.2 
SP44 -21 0 
SI45 0 80.2 
SP45 -21 0 
SI46 0 5 
SP46 -21 0 
C 
C Tally Cards 
c Back Right Lung 
F8:P 502 
E8 0 1e-8 0.005 1024i 2.046  
FT8 SCX 2  GEB -0.00298579 0.0925102 -0.4 
c Front Right Lung 
F18:P 522 
E18 0 1e-8 0.005 1024i 2.046 
FT18 SCX 2 GEB -0.00298579 0.0925102 -0.4  
c Front Neck Under Chin 
F28:P 542 
E28 0 1e-8 0.005 1024i 2.046 
FT28 SCX 2 GEB -0.00298579 0.0925102 -0.4 
c Outer Left Leg 
F38:P 562 
E38 0 1e-8 0.005 1024i 2.046 
FT38 SCX 2 GEB -0.00298579 0.0925102 -0.4 
C 
C Material Cards 
C       THIS IS THE COMPOSITION FOR AIR 
M1    7014 -.7558 8016 -.2314 18000 -.0128 
C      THIS IS THE COMPOSITION FOR LUNG TISSUE 
M2    1001 -.1021 
      6012 -.1001 
      7014 -.0280 
      8016 -.7596 
     11023 -.0019 
     15031 -.0008 
     16032 -.0023 
     17000 -.0027 
     19000 -.0020 
     20000 -.0001 
     26000 -.0004 
C        THE COMPOSITION FOR TOTAL BODY MINUS SKELETON AND LUNGS 
M3    1001 -.1047 
      6012 -.2302 
      7014 -.0234 
      8016 -.6321 
     11023 -.0013 
     12000 -.0002 
     15031 -.0024 
     16032 -.0022 
     17000 -.0014 
     19000 -.0021 
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C      THE COMPOSITION FOR SKELETAL TISSUE 
M4    1001 -.0704 
      6012 -.2279 
      8016 -.4856 
      7014 -.0387 
     11023 -.0032 
     12000 -.0011 
     15031 -.0694 
     16032 -.0017 
     17000 -.0014 
     19000 -.0015 
     20000 -.0991 
c      Adult Tissues (Density = 1.04 g/cc) 
M5       1001  -0.10454 
         6012  -0.22663 
         7014  -0.02490 
         8016  -0.63525 
        11023  -0.00112 
        12000  -0.00013 
        14000  -0.00030 
        15031  -0.00134 
        16032  -0.00204 
        17000  -0.00133 
        19000  -0.00208 
        20000  -0.00024 
        26000  -0.00005 
        30000  -0.00003 
        37085  -0.000007217 
        37087  -0.000002783 
        40000  -0.00001 
c Detectors Materials 
c Material Card for Air (NIST DRY AIR)                
m501  8016.             -0.232   
      7014.             -0.755 
      6012              -1.20E-4 
      18000.42c         -1.28E-2  
c Material Card for Sodium Iodide   
m502  11000.04p           0.5   
      53000.04p           0.5  
c Material Card for grain controlled mild steel  
m503  26054            -0.05821 
      26056            -0.9137 
      26057            -0.0211 
      26058            -0.00281 
       6012            -0.0006 
      25055            -0.0035 
      15031            -0.00004 
      16000            -0.00005 
c Material Card for Aluminum           
m506  13027.  1   
c Material Card for Antimonial Lead 
m508  82000   0.96 
      51000   0.04 
c Material Card for High Brass 
m509  29000    0.65 
      30000    0.35 
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c Material Card for Pure Lead 
m510  82000   1 
lost 50 
c STOP NPS 1E8 F38 0.01 
NPS 4E9 
RAND GEN=2 SEED=1561615651 







MIRD PHANTOM RESULTS FOR Cs-137, Co-60, Am-241, I-131, Ir-192 
98 
Table D.1 Count rate per Bq calculated for the Male phantom contaminated with Cs-137 
Back Right Lung Front Right Lung Neck Thigh 
  cpm per Bq cpm per Bq cpm per Bq cpm per Bq 
0 1.85E-04 1.77E-04 1.51E-05 1.31E-06 
1 4.29E-04 4.63E-04 5.07E-04 2.47E-04 
2 4.11E-04 4.48E-04 5.20E-04 2.54E-04 
3 3.94E-04 4.30E-04 5.08E-04 2.49E-04 
4 3.83E-04 4.19E-04 4.99E-04 2.44E-04 
5 3.76E-04 4.11E-04 4.91E-04 2.40E-04 
6 3.71E-04 4.05E-04 4.84E-04 2.37E-04 
7 3.66E-04 4.00E-04 4.79E-04 2.35E-04 
8 3.63E-04 3.97E-04 4.74E-04 2.32E-04 
9 3.60E-04 3.93E-04 4.70E-04 2.30E-04 
10 3.57E-04 3.90E-04 4.66E-04 2.28E-04 


















30 3.13E-04 3.42E-04 4.09E-04 2.00E-04 
 
 
Table D.2 Count rate per Bq calculated for the Female phantom contaminated with Cs-137 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 1.73E-04 1.49E-05 1.59E-06 
1 5.41E-04 6.39E-04 2.37E-04 
2 5.29E-04 6.56E-04 2.43E-04 
3 5.09E-04 6.42E-04 2.39E-04 
4 4.97E-04 6.30E-04 2.34E-04 
5 4.88E-04 6.20E-04 2.30E-04 
6 4.81E-04 6.12E-04 2.27E-04 
7 4.76E-04 6.05E-04 2.25E-04 
8 4.71E-04 5.99E-04 2.23E-04 
9 4.67E-04 5.94E-04 2.21E-04 
10 4.63E-04 5.89E-04 2.19E-04 


























Table D.3 Count rate per Bq calculated for the Adipose Male phantom contaminated with Cs-137 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 1.22E-04 1.03E-05 6.41E-07 
1 3.67E-04 5.80E-04 2.29E-04 
2 3.58E-04 5.96E-04 2.36E-04 
3 3.45E-04 5.84E-04 2.31E-04 
4 3.36E-04 5.73E-04 2.27E-04 
5 3.30E-04 5.64E-04 2.23E-04 
6 3.26E-04 5.56E-04 2.20E-04 
7 3.22E-04 5.50E-04 2.18E-04 
8 3.19E-04 5.45E-04 2.16E-04 
9 3.16E-04 5.40E-04 2.14E-04 
10 3.14E-04 5.36E-04 2.12E-04 


















30 2.75E-04 4.70E-04 1.86E-04 
 
Table D.4 Count rate per Bq calculated for the Adipose Female phantom contaminated with Cs-137 
Back Right Lung Neck Thigh 
 cpm per Bq cpm per Bq cpm per Bq 
0 1.29E-04 1.14E-05 9.44E-07 
1 4.21E-04 5.63E-04 3.30E-04 
2 4.12E-04 5.78E-04 3.40E-04 
3 3.97E-04 5.66E-04 3.33E-04 
4 3.88E-04 5.55E-04 3.27E-04 
5 3.81E-04 5.46E-04 3.21E-04 
6 3.76E-04 5.39E-04 3.17E-04 
7 3.71E-04 5.33E-04 3.14E-04 
8 3.68E-04 5.28E-04 3.11E-04 
9 3.64E-04 5.23E-04 3.08E-04 
10 3.62E-04 5.19E-04 3.06E-04 






























Table D.5 Count rate per Bq calculated for the Post-Menopausal Adipose Female phantom contaminated 
with Cs-137 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 2.09E-05 7.59E-06 8.40E-07 
1 1.10E-04 1.55E-04 5.54E-05 
2 1.10E-04 1.58E-04 5.68E-05 
3 1.06E-04 1.55E-04 5.57E-05 
4 1.04E-04 1.52E-04 5.46E-05 
5 1.02E-04 1.49E-04 5.37E-05 
6 1.01E-04 1.48E-04 5.31E-05 
7 9.98E-05 1.46E-04 5.25E-05 
8 9.89E-05 1.44E-04 5.20E-05 
9 9.80E-05 1.43E-04 5.15E-05 
10 9.72E-05 1.42E-04 5.11E-05 


















30 8.52E-05 1.25E-04 4.48E-05 
 
 
Table D.6 Count rate per Bq calculated for the Child phantom contaminated with Cs-137 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 2.28E-04 1.90E-05 0.00E+00 
1 7.00E-04 7.43E-04 3.86E-04 
2 6.82E-04 7.62E-04 3.98E-04 
3 6.57E-04 7.45E-04 3.90E-04 
4 6.41E-04 7.31E-04 3.83E-04 
5 6.29E-04 7.20E-04 3.77E-04 
6 6.21E-04 7.10E-04 3.72E-04 
7 6.13E-04 7.03E-04 3.68E-04 
8 6.07E-04 6.96E-04 3.64E-04 
9 6.02E-04 6.90E-04 3.61E-04 
10 5.97E-04 6.84E-04 3.58E-04 

































Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq cpm per Bq 
0 2.76E-04 2.65E-04 6.39E-05 6.55E-06 
1 1.30E-04 1.33E-04 5.24E-05 2.04E-05 
2 1.06E-04 1.08E-04 4.85E-05 2.02E-05 
3 9.57E-05 9.63E-05 4.53E-05 1.83E-05 
4 9.04E-05 9.07E-05 4.30E-05 1.70E-05 
5 8.72E-05 8.74E-05 4.13E-05 1.60E-05 
6 8.49E-05 8.50E-05 3.99E-05 1.53E-05 
7 8.30E-05 8.31E-05 3.87E-05 1.48E-05 
8 8.14E-05 8.14E-05 3.77E-05 1.43E-05 
9 7.99E-05 7.99E-05 3.68E-05 1.39E-05 
10 7.85E-05 7.84E-05 3.59E-05 1.35E-05 


















30 6.15E-05 6.15E-05 2.84E-05 1.07E-05 
 
 
Table D.8 Count Rate per Bq calculated for the Female phantom contaminated with Co-60 
Back Right Lung Neck Thigh 
  cpm per Bq cpm per Bq cpm per Bq 
0 2.63E-04 6.44E-05 7.69E-06 
1 1.29E-04 6.30E-05 2.09E-05 
2 1.08E-04 6.09E-05 2.04E-05 
3 9.77E-05 5.76E-05 1.85E-05 
4 9.24E-05 5.49E-05 1.71E-05 
5 8.92E-05 5.27E-05 1.61E-05 
6 8.68E-05 5.09E-05 1.54E-05 
7 8.48E-05 4.93E-05 1.48E-05 
8 8.30E-05 4.79E-05 1.44E-05 
9 8.14E-05 4.67E-05 1.39E-05 
10 7.99E-05 4.56E-05 1.36E-05 




























Table D.9 Count Rate per Bq calculated for the Adipose Male Phantom contaminated with Co-60 
Back Right Lung  Neck Thigh 
  cpm per Bq cpm per Bq cpm per Bq 
0 1.92E-04 4.73E-05 3.98E-06 
1 9.29E-05 5.11E-05 1.81E-05 
2 7.81E-05 5.11E-05 1.85E-05 
3 7.11E-05 4.89E-05 1.71E-05 
4 6.73E-05 4.68E-05 1.59E-05 
5 6.50E-05 4.50E-05 1.51E-05 
6 6.32E-05 4.34E-05 1.44E-05 
7 6.18E-05 4.20E-05 1.39E-05 
8 6.05E-05 4.08E-05 1.34E-05 
9 5.93E-05 3.97E-05 1.30E-05 
10 5.83E-05 3.87E-05 1.27E-05 


















30 4.57E-05 3.07E-05 1.01E-05 
 
Table D.10 Count rate per Bq calculated for the Adipose Female phantom contaminated with Co-60 
Back Right Lung Neck Thigh 
  cpm per Bq cpm per Bq cpm per Bq 
0 1.98E-04 5.08E-05 5.14E-06 
1 9.92E-05 5.24E-05 2.23E-05 
2 8.39E-05 5.18E-05 2.37E-05 
3 7.64E-05 4.94E-05 2.25E-05 
4 7.23E-05 4.72E-05 2.13E-05 
5 6.97E-05 4.54E-05 2.02E-05 
6 6.78E-05 4.38E-05 1.94E-05 
7 6.62E-05 4.24E-05 1.87E-05 
8 6.48E-05 4.12E-05 1.81E-05 
9 6.36E-05 4.01E-05 1.75E-05 
10 6.24E-05 3.92E-05 1.71E-05 































Table D.11 Count rate per Bq calculated for the Post-Menopausal Adipose Female phantom contaminated 
with Co-60 
Back Right Lung Neck Thigh 
  cpm per Bq cpm per Bq cpm per Bq 
0 2.03E-04 5.33E-05 4.94E-06 
1 9.89E-05 5.60E-05 1.59E-05 
2 8.29E-05 5.58E-05 1.58E-05 
3 7.52E-05 5.34E-05 1.45E-05 
4 7.11E-05 5.11E-05 1.34E-05 
5 6.86E-05 4.91E-05 1.27E-05 
6 6.68E-05 4.74E-05 1.21E-05 
7 6.52E-05 4.59E-05 1.17E-05 
8 6.39E-05 4.45E-05 1.13E-05 
9 6.26E-05 4.34E-05 1.09E-05 
10 6.15E-05 4.23E-05 1.07E-05 


















30 4.82E-05 3.35E-05 8.47E-06 
 
 
Table D.12 Count rate per Bq calculated for the Child phantom contaminated with Co-60 
Back Right Lung Neck Thigh 
  cpm per Bq cpm per Bq cpm per Bq 
0 3.36E-04 6.67E-05 1.91E-05 
1 1.65E-04 7.32E-05 3.00E-05 
2 1.38E-04 6.96E-05 2.75E-05 
3 1.25E-04 6.53E-05 2.44E-05 
4 1.18E-04 6.19E-05 2.24E-05 
5 1.14E-04 5.93E-05 2.11E-05 
6 1.11E-04 5.72E-05 2.02E-05 
7 1.08E-04 5.54E-05 1.95E-05 
8 1.06E-04 5.38E-05 1.89E-05 
9 1.04E-04 5.23E-05 1.84E-05 
10 1.02E-04 5.11E-05 1.79E-05 





























Table D.13 Count rate per Bq calculated for the Male phantom contaminated with Am-241 
Back Right Lung Front Right Lung Neck Thigh   
  cpm per Bq cpm per Bq Cpm per Bq cpm per Bq 
0 7.16E-05 6.84E-05 4.75E-07 0.00E+00 
1 3.19E-05 2.59E-05 1.45E-06 6.48E-07 
2 2.65E-05 2.04E-05 1.02E-06 4.42E-07 
3 2.46E-05 1.82E-05 8.57E-07 3.35E-07 
4 2.38E-05 1.73E-05 8.00E-07 2.91E-07 
5 2.35E-05 1.68E-05 7.81E-07 2.75E-07 
6 2.34E-05 1.66E-05 7.77E-07 2.70E-07 
7 2.33E-05 1.63E-05 7.79E-07 2.70E-07 
8 2.32E-05 1.61E-05 7.83E-07 2.72E-07 
9 2.31E-05 1.59E-05 7.87E-07 2.74E-07 
10 2.31E-05 1.58E-05 7.92E-07 2.76E-07 


















30 2.23E-05 1.29E-05 8.62E-07 3.12E-07 
 
 
Table D.14 Count rate per Bq calculated for the Female phantom contaminated with Am-241 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 6.49E-05 5.64E-07 0.00E+00 
1 3.27E-05 1.53E-06 6.99E-07 
2 2.83E-05 1.08E-06 4.75E-07 
3 2.67E-05 9.09E-07 3.54E-07 
4 2.62E-05 8.49E-07 3.02E-07 
5 2.60E-05 8.29E-07 2.84E-07 
6 2.60E-05 8.24E-07 2.78E-07 
7 2.60E-05 8.26E-07 2.78E-07 
8 2.60E-05 8.30E-07 2.79E-07 
9 2.60E-05 8.34E-07 2.81E-07 
10 2.61E-05 8.39E-07 2.84E-07 






























Table D.15 Count rate per Bq calculated for the Adipose Male phantom contaminated with Am-241 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 4.15E-05 4.52E-07 4.52E-07 
1 2.10E-05 1.38E-06 1.38E-06 
2 1.82E-05 9.69E-07 9.69E-07 
3 1.72E-05 8.17E-07 8.17E-07 
4 1.68E-05 7.62E-07 7.62E-07 
5 1.67E-05 7.45E-07 7.45E-07 
6 1.67E-05 7.41E-07 7.41E-07 
7 1.67E-05 7.43E-07 7.43E-07 
8 1.67E-05 7.46E-07 7.46E-07 
9 1.68E-05 7.50E-07 7.50E-07 
10 1.68E-05 7.55E-07 7.55E-07 


















30 1.76E-05 8.21E-07 8.21E-07 
 
 
Table D.16 Count rate per Bq calculated for the Adipose Female phantom contaminated with Am-241 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 5.13E-05 5.26E-07 1.33E-09 
1 2.55E-05 1.43E-06 1.17E-06 
2 2.19E-05 1.00E-06 8.01E-07 
3 2.07E-05 8.48E-07 6.39E-07 
4 2.02E-05 7.92E-07 5.76E-07 
5 2.01E-05 7.73E-07 5.54E-07 
6 2.00E-05 7.69E-07 5.49E-07 
7 2.00E-05 7.70E-07 5.51E-07 
8 2.01E-05 7.74E-07 5.55E-07 
9 2.01E-05 7.78E-07 5.59E-07 
10 2.01E-05 7.82E-07 5.64E-07 





























Table D.17 Count rate per Bq calculated for the Post-Menopausal Adipose Female phantom contaminated 
with Am-241 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 4.49E-05 5.74E-07 0.00E+00 
1 2.29E-05 1.51E-06 5.28E-07 
2 1.98E-05 1.06E-06 3.59E-07 
3 1.88E-05 8.98E-07 2.66E-07 
4 1.84E-05 8.38E-07 2.27E-07 
5 1.83E-05 8.18E-07 2.13E-07 
6 1.83E-05 8.14E-07 2.09E-07 
7 1.83E-05 8.16E-07 2.09E-07 
8 1.83E-05 8.19E-07 2.10E-07 
9 1.84E-05 8.24E-07 2.11E-07 
10 1.84E-05 8.28E-07 2.13E-07 


















30 1.93E-05 8.95E-07 2.40E-07 
 
 
Table D.18 Count rate per Bq calculated for the Child phantom contaminated with Am-241 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 1.11E-04 1.87E-06 0.00E+00 
1 5.02E-05 3.39E-06 1.15E-06 
2 4.18E-05 2.41E-06 7.54E-07 
3 3.87E-05 2.04E-06 5.17E-07 
4 3.75E-05 1.91E-06 4.15E-07 
5 3.70E-05 1.86E-06 3.76E-07 
6 3.67E-05 1.85E-06 3.63E-07 
7 3.66E-05 1.85E-06 3.60E-07 
8 3.65E-05 1.86E-06 3.61E-07 
9 3.64E-05 1.87E-06 3.63E-07 
10 3.63E-05 1.87E-06 3.66E-07 





























Table D.19 Count rate per Bq calculated for the Male phantom contaminated with I-131 
Back Right Lung Front Right Lung Neck Thigh 
 cpm per Bq cpm per Bq cpm per Bq cpm per Bq 
0 2.86E-04 2.75E-04 2.42E-06 1.90E-07 
1 3.35E-05 3.28E-05 8.61E-05 1.02E-06 
2 1.11E-05 1.16E-05 8.14E-05 6.12E-07 
3 4.69E-06 5.36E-06 7.48E-05 8.07E-07 
4 2.71E-06 3.41E-06 6.86E-05 9.83E-07 
5 2.15E-06 2.82E-06 6.28E-05 1.11E-06 
6 2.02E-06 2.65E-06 5.76E-05 1.20E-06 
7 2.01E-06 2.60E-06 5.27E-05 1.26E-06 
8 2.02E-06 2.57E-06 4.83E-05 1.29E-06 
9 2.02E-06 2.52E-06 4.42E-05 1.29E-06 
10 1.99E-06 2.46E-06 4.05E-05 1.28E-06 

















30 6.10E-07 6.91E-07 6.67E-06 3.97E-07 
 
  
Table D.20 Count rate per Bq calculated for the Female phantom contaminated with I-131 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 2.66E-04 2.38E-06 2.51E-07 
1 3.17E-05 7.16E-05 9.49E-07 
2 1.09E-05 6.75E-05 5.65E-07 
3 4.99E-06 6.21E-05 7.42E-07 
4 3.26E-06 5.71E-05 9.03E-07 
5 2.80E-06 5.24E-05 1.02E-06 
6 2.73E-06 4.81E-05 1.10E-06 
7 2.75E-06 4.41E-05 1.15E-06 
8 2.77E-06 4.05E-05 1.18E-06 
9 2.77E-06 3.71E-05 1.19E-06 
10 2.73E-06 3.40E-05 1.18E-06 






























Table D.21 Count rate per Bq calculated for the Adipose Male phantom contaminated with I-131 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 1.83E-04 1.77E-06 1.07E-07 
1 2.18E-05 7.53E-05 9.03E-07 
2 7.44E-06 7.13E-05 5.42E-07 
3 3.39E-06 6.55E-05 7.19E-07 
4 2.18E-06 6.01E-05 8.77E-07 
5 1.86E-06 5.51E-05 9.94E-07 
6 1.81E-06 5.05E-05 1.07E-06 
7 1.82E-06 4.63E-05 1.12E-06 
8 1.83E-06 4.24E-05 1.15E-06 
9 1.82E-06 3.88E-05 1.16E-06 
10 1.80E-06 3.55E-05 1.15E-06 


















30 5.45E-07 5.87E-06 3.56E-07 
 
 
Table D.22 Count rate per Bq calculated for the Adipose Female phantom contaminated with I-131 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 1.99E-04 1.85E-06 1.76E-07 
1 2.39E-05 6.05E-05 1.37E-06 
2 8.20E-06 5.71E-05 8.45E-07 
3 3.79E-06 5.26E-05 1.12E-06 
4 2.48E-06 4.83E-05 1.37E-06 
5 2.13E-06 4.44E-05 1.55E-06 
6 2.07E-06 4.07E-05 1.68E-06 
7 2.08E-06 3.74E-05 1.75E-06 
8 2.09E-06 3.43E-05 1.79E-06 
9 2.09E-06 3.14E-05 1.80E-06 
10 2.06E-06 2.88E-05 1.79E-06 





























Table D.23 Count rate per Bq calculated for the Post-Menopausal Adipose Female phantom contaminated 
with I-131 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 1.94E-04 2.01E-06 1.63E-07 
1 2.32E-05 6.84E-05 6.89E-07 
2 7.94E-06 6.46E-05 4.05E-07 
3 3.64E-06 5.94E-05 5.29E-07 
4 2.35E-06 5.46E-05 6.42E-07 
5 2.00E-06 5.01E-05 7.25E-07 
6 1.93E-06 4.60E-05 7.82E-07 
7 1.93E-06 4.22E-05 8.18E-07 
8 1.94E-06 3.87E-05 8.37E-07 
9 1.93E-06 3.55E-05 8.41E-07 
10 1.90E-06 3.26E-05 8.34E-07 


















30 5.67E-07 5.46E-06 2.58E-07 
 
 
Table D.24 Count rate per Bq for the Child phantom contaminated with I-131 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 3.65E-04 2.22E-06 8.02E-07 
1 4.48E-05 5.43E-05 1.20E-06 
2 1.54E-05 5.06E-05 7.16E-07 
3 7.28E-06 4.71E-05 8.96E-07 
4 4.88E-06 4.38E-05 1.07E-06 
5 4.24E-06 4.06E-05 1.19E-06 
6 4.13E-06 3.77E-05 1.28E-06 
7 4.14E-06 3.49E-05 1.33E-06 
8 4.15E-06 3.23E-05 1.36E-06 
9 4.13E-06 2.98E-05 1.37E-06 
10 4.06E-06 2.75E-05 1.35E-06 





























Table D.25 Count Rate per Bq for the Male Phantom Contaminated with I-192 
Back Right Lung Front Right Lung Neck Thigh 
  cpm per Bq cpm per Bq cpm per Bq cpm per Bq 
0 3.45E-04 3.31E-04 3.07E-06 1.73E-07 
1 1.35E-04 1.30E-04 1.76E-05 9.62E-06 
2 1.08E-04 1.04E-04 1.82E-05 9.45E-06 
3 9.71E-05 9.38E-05 1.80E-05 8.88E-06 
4 9.19E-05 8.88E-05 1.78E-05 8.58E-06 
5 8.89E-05 8.59E-05 1.77E-05 8.43E-06 
6 8.67E-05 8.38E-05 1.77E-05 8.36E-06 
7 8.48E-05 8.20E-05 1.76E-05 8.31E-06 
8 8.31E-05 8.04E-05 1.75E-05 8.28E-06 
9 8.15E-05 7.88E-05 1.74E-05 8.25E-06 
10 7.99E-05 7.73E-05 1.74E-05 8.22E-06 


















30 5.59E-05 5.43E-05 1.63E-05 7.77E-06 
 
 
Table D.26 Count rate per Bq for the Female phantom contaminated with I-192 
Back Right Lung Neck Thigh 
 cpm per Bq cpm per Bq cpm per Bq 
0 3.21E-04 3.14E-06 2.19E-07 
1 1.30E-04 1.84E-05 8.94E-06 
2 1.05E-04 1.90E-05 8.73E-06 
3 9.47E-05 1.88E-05 8.16E-06 
4 8.98E-05 1.87E-05 7.86E-06 
5 8.70E-05 1.85E-05 7.72E-06 
6 8.50E-05 1.85E-05 7.65E-06 
7 8.32E-05 1.84E-05 7.61E-06 
8 8.16E-05 1.83E-05 7.58E-06 
9 8.01E-05 1.82E-05 7.55E-06 
10 7.86E-05 1.82E-05 7.52E-06 





























Table D.27 Count rate per Bq for the Adipose Male phantom contaminated with I-192 
Back Right Lung Neck Thigh 
  cpm per Bq cpm per Bq cpm per Bq 
0 2.23E-04 2.41E-06 7.28E-08 
1 8.97E-05 1.60E-05 8.57E-06 
2 7.24E-05 1.65E-05 8.44E-06 
3 6.53E-05 1.64E-05 7.94E-06 
4 6.19E-05 1.63E-05 7.67E-06 
5 6.00E-05 1.62E-05 7.55E-06 
6 5.86E-05 1.61E-05 7.48E-06 
7 5.73E-05 1.61E-05 7.44E-06 
8 5.62E-05 1.60E-05 7.41E-06 
9 5.52E-05 1.59E-05 7.38E-06 
10 5.42E-05 1.59E-05 7.36E-06 


















30 3.85E-05 1.49E-05 6.95E-06 
 
 
Table D.28 Count rate per Bq for the Adipose Female phantom contaminated with I-192 
Back Right Lung Neck Thigh 
  cpm per Bq cpm per Bq cpm per Bq 
0 2.45E-04 2.37E-06 1.69E-07 
1 9.91E-05 1.56E-05 1.24E-05 
2 8.01E-05 1.61E-05 1.27E-05 
3 7.23E-05 1.60E-05 1.23E-05 
4 6.86E-05 1.59E-05 1.20E-05 
5 6.65E-05 1.58E-05 1.19E-05 
6 6.49E-05 1.57E-05 1.18E-05 
7 6.36E-05 1.57E-05 1.18E-05 
8 6.23E-05 1.56E-05 1.17E-05 
9 6.12E-05 1.55E-05 1.17E-05 
10 6.00E-05 1.55E-05 1.17E-05 































Table D.29 Count rate per Bq for the Post-Menopausal Adipose Female phantom contaminated with I-192 
Back Right Lung Neck Thigh 
  cpm per Bq cpm per Bq cpm per Bq 
0 2.40E-04 2.66E-06 7.67E-08 
1 9.63E-05 1.75E-05 6.71E-06 
2 7.77E-05 1.82E-05 6.43E-06 
3 7.00E-05 1.80E-05 5.90E-06 
4 6.64E-05 1.79E-05 5.63E-06 
5 6.43E-05 1.78E-05 5.51E-06 
6 6.28E-05 1.77E-05 5.45E-06 
7 6.14E-05 1.76E-05 5.42E-06 
8 6.02E-05 1.76E-05 5.39E-06 
9 5.91E-05 1.75E-05 5.37E-06 
10 5.80E-05 1.74E-05 5.36E-06 


















30 4.12E-05 1.64E-05 5.06E-06 
 
 
Table D.30 Count rate per Bq for the Child phantom contaminated with I-192 
Back Right Lung Neck Thigh   
  cpm per Bq cpm per Bq cpm per Bq 
0 4.41E-04 4.31E-06 5.75E-07 
1 1.80E-04 3.12E-05 1.09E-05 
2 1.45E-04 3.23E-05 1.04E-05 
3 1.31E-04 3.20E-05 9.55E-06 
4 1.25E-04 3.17E-05 9.12E-06 
5 1.21E-04 3.16E-05 8.93E-06 
6 1.18E-04 3.14E-05 8.83E-06 
7 1.16E-04 3.13E-05 8.77E-06 
8 1.13E-04 3.12E-05 8.73E-06 
9 1.11E-04 3.10E-05 8.70E-06 
10 1.09E-04 3.09E-05 8.67E-06 
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